Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
CURRICULUM VITAE QUAN DONG NGUYEN, MD, MSC Name: DEMOGRAPHIC AND PERSONAL INFORMATION CURRENT POSITION McGaw Memorial Endowed Chair in Ophthalmology Professor and Chair of Ophthalmology Director of the Stanley M. Truhlsen Eye Institute University of Nebraska Medical Center Address: Stanley M. Truhlsen Eye Institute University of Nebraska Medical Center 3902 Leavenworth Street Omaha, Nebraska Phone: (402) 559-4276 Fax: (402) 559-5514 E-mail: [email protected] EDUCATION AND TRAINING Education: 1985 1989 1989 1993 Bacc. Phillips Exeter Academy B.S. Yale University Molecular Biophysics and Biochemistry M.Sc. Yale Graduate School of Arts and Sciences Molecular Biophysics and Biochemistry M.D. University of Pennsylvania School of Medicine Post-Doctoral Training: Internship 1993-1994 Massachusetts General Hospital Department of Internal Medicine, Harvard Medical School Residency 1994-1997 Massachusetts Eye and Ear Infirmary Department of Ophthalmology, Harvard Medical School Clinical and Research Fellowships 1997-1998 Immunology and Uveitis Massachusetts Eye and Ear Infirmary, Harvard Medical School 1998-1999 Ocular Immunology Wilmer Eye Institute, Johns Hopkins University and Hospitals 1999-2001 Medical and Surgical Diseases of the Retina and Vitreous 2 Schepens Eye Research Institute Massachusetts Eye and Ear Infirmary, Harvard Medical School PROFESSIONAL EXPERIENCES 1997-1998 1998-1999 1999-2001 2001-2008 2008-2013 2013- Fellow in Ophthalmology, Harvard Medical School Assistant in Ophthalmology, Johns Hopkins University School of Medicine Fellow in Ophthalmology, Harvard Medical School Post-Doctoral Research Scientist, Schepens Eye Research Institute Assistant Professor of Ophthalmology Wilmer Ophthalmological Institute The Johns Hopkins University School of Medicine Associate Professor of Ophthalmology Wilmer Ophthalmological Institute The Johns Hopkins University School of Medicine Director Retinal Imaging Research and Reading Center Wilmer Ophthalmological Institute The Johns Hopkins University School of Medicine Director Medical Student Education in Ophthalmology The Johns Hopkins University School of Medicine McGaw Memorial Endowed Professor of Ophthalmology Director Stanley M. Truhlsen Eye Institute University of Nebraska Medical Center RESEARCH ACTIVITIES EXTRAMURAL FUNDING (Previous, Current, and Pending) Dates: September 1, 2001 to August 31, 2006 Title: Supplemental Inspired Oxygen for Hypoxia-Related Retinal Diseases Identification: EY 13552-01 Sponsor: National Eye Institute, National Institutes of Health Role: Principal Investigator Percent effort: 90% Notes: This grant was funded as a K23 Career Development Award. Dates: September 1, 2003 to August 30, 2005 Title: An Open Label, Pilot (Phase I/II), Dose Escalation Safety and Tolerability Study of Combretastatin A4 Phosphate in Patients with Neovascular Age-Related Macular Degeneration Identification: Young Investigator Award 3 Sponsor: Foundation Fighting Blindness, Inc. Role: Principal Investigator Percent effort: 10% Dates: September 1, 2005 to August 30, 2006 Title: A Pilot, Open-Label, Dose-Escalation Study of the Safety, Tolerability, and Efficacy of Multiple Intravitreal Injections of Ranibizumab in Subjects with Macular Edema Secondary to Diabetes Mellitus Identification: Innovative Grant Award Sponsor: Juvenile Diabetes Research Foundation, Inc. Role: Principal Investigator Percent effort: 5% Dates: January 2, 2007 to January 1, 2011 Title: Ranibizumab for Edema of the mAcula in Diabetes: A Phase 2 Multi-Center Randomized Controlled Study – The READ 2 Study Identification: Clinical Research Grant Award Sponsor: Juvenile Diabetes Research Foundation, Inc. Role: Study Chairman and Chair of the Executive Committee Percent effort: 45% Notes: The READ 2 study design is based on the results from the phase 1 study that was also supported by JDRF through the Innovative Grant Award. There are 14 centers across the United States that participate in the READ 2 study. Dates: March 1, 2008 to February 28, 2011 Title: Novel Assessment of Early Changes in Diabetic Retinopathy Identification: 1RO1EY017577-01 Sponsor: National Eye Institute, National Institutes of Health Role: Principal Investigator Percent effort: 15% for year 1, 25% for years 2 and 3 Notes: The study is a collaboration among the clinician scientists, physicists, and engineers at Johns Hopkins University, Catholic University of America, and the Oregon Health and Science University. Dates: February 1, 2010 to January 31, 2013 Title: Ranibizumab for Edema of the mAcula in Diabetes: Protocol 3 with High Dose Multi-Center Randomized Controlled Study – The READ 3 Study Identification: Clinical Research Grant Award Sponsor: Juvenile Diabetes Research Foundation, Inc. Role: Study Chairman and Chair of the Executive Committee Percent effort: 35% Notes: The READ 3 study design is based on the results from the READ 1 and READ 2 studies that were also supported by JDRF. There are 15 centers across the United States that participate in the READ 3 study. 4 Dates: May 1, 2010 to April 30, 2012 Title: Mechanisms of Glucose Toxicity Identification: 1R24DK084949-01 Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health Role: Principal Investigator for Ophthalmology Percent effort: 10% Notes: The study is a collaboration among the clinician scientists and chemists from five disciplines (Biological Chemistry, Neurology, Nephrology, Cardiology, and Ophthalmology) at Johns Hopkins University. Dates: April 1, 2012 to March 31, 2014 Title: A Randomized, Multi-center, Phase II Study of the Safety, Tolerability, and Bioactivity of Repeated Intravitreal Injections of iCo-007 as Monotherapy or in Combination with Ranibizumab or Laser Photocoagulation in the Treatment of Diabetic Macular Edema with Involvement of the FoveAL Center (the iDEAL Study) Identification: Clinical Research Grant Award Sponsor: Juvenile Diabetes Research Foundation, Inc. Role: Study Chairman and Chair of the Executive Committee Percent effort: 25% Notes: The iDEAL Study is a collaborative effort among the Juvenile Diabetes Research Foundation, iCo Therapeutics, and the Johns Hopkins University to investigate the role of a C-raf kinase inhibitor in diabetic macular edema. The Study is being conducted across 25 centers in the United States. PUBLICATIONS Original Peer-Reviewed Research Articles 1. Raha D, Nguyen QD, Garen A. “Molecular and Developmental Analyses of the Protein Encoded by the Drosophila Gene ectodermal.” Developmental Genetics. 1990;11: 310-317. 2. Nguyen QD, Foster CS. “Ciliary Body Melanoma Masquerading as Chronic Uveitis.” Ocular Immunology and Inflammation. 1998; 6: 253-256. 3. Nguyen QD, Kempen JH, Bolton SG, Dunn JP, and Jabs DA. “Immune Recovery Uveitis in Patients with AIDS and Cytomegalovirus Retinitis Following Highly Active Antiretroviral Therapy.” American Journal of Ophthalmology. 2000; 129: 634-639. 5 4. Nguyen QD, Uy HS, Akpek EK, Harper SL, Zacks DN, Foster CS. “Choroidopathy of Systemic Lupus Erythematosus.” Lupus. 2000; 9: 288-298. 5. Nguyen QD, Humphrey RL, Dunn JP, Humayun MS. “Elevated Vitreous Concentration of Monoclonal Immunoglobulin Presenting as Schlieren in Juvenile Rheumatoid Arthritis-Associated Uveitis.” Archives of Ophthalmology. 2001; 119: 293-296. 6. Uy HS, Nguyen QD, Arbour J, Gravel M, D’Amico DJ, Jakobiec FA, Foster CS. “Sclerosing Pseudotumor of the Eye.” Archives of Ophthalmology. 2001; 119: 603607. 7. Letko E, Stechschulte SU, Kenyon KR, Sadeq N, Romero TR, Samson CM, Nguyen QD, Harper SL, Primack JD, Azar DT, Gruterich M, Dohlman CH, Baltatzis S, Foster CS. “Amniotic Membrane Inlay and Overlay Grafting for Corneal Epithelial Defects and Stromal Ulcers.” Archives of Ophthalmology. 2001; 119: 659-663. 8. Nguyen QD, Lashkari K, Hirose T, Pruett RC, McMeel JW, Schepens CL. “Erosion and Intrusion of Silicone Scleral Buckle: Presentation and Management.” Retina. 2001; 21: 214-220. 9. Nguyen QD, Uy HS, Merchant A, Medina CA, Baltatzis, Zhao T, Zhao ZS, Cantor H, Foster CS. “Effect of Fas and Fas-Ligand Deficiency in Resistance of C57BL/6 Mice to HSV-1 Keratitis and Chorioretinitis.” Investigative Ophthalmology and Visual Science. 2001; 42: 2505-2509. 10. Harper SL, Letko E, Samson CM, Zafirakis P, Sangwan V, Nguyen QD, Uy H, Baltatzis S, Foster CS. “Wegener’s Granulomatosis: the Relationship between Ocular and Systemic Disease.” Journal of Rheumatology. 2001; 28: 1025-1032. 11. Rasmussen H, Chu KW, Campochiaro P, Gehlbach PL, Haller, JA, Handa JT, Nguyen QD, Sung JU. “Clinical Protocol. An Open-Label, Phase I, Single Administration, Dose-Escalation Study of ADGVPEDF.11D (ADPEDF) in Neovascular Age-Related Macular Degeneration (AMD).” Human Gene Therapy. 2001; 12: 2029-2032. 12. Nguyen QD, Kruger EF, Kim AJ, Lashkari MH, Lashkari K. “Combat Eye Trauma: Intraocular Foreign Body during the Iran-Iraq War 1980-1988.” International Ophthalmology Clinics. 2002; 42: 167-177. 13. Papaliodis GN, Nguyen QD, Samson CM, Foster CS. “Intraocular Lens Tolerance in Surgery for Cataracta Complicata: Assessment of Four Implant Materials.” Seminars in Ophthalmology. 2002; 17: 120-123. 6 14. Nguyen QD, Do DV, Feke GT, Demirjian ZN, Lashkari K. “Heparin-Induced Antiheparin-Platelet Antibody Associated with Retinal Venous Thrombosis.” Ophthalmology. 2003; 100: 600-603. 15. EyeTech Study Group. “Anti-Vascular Endothelial Growth Factor Therapy for Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration: Phase II Study Results.” Ophthalmology. 2003; 110: 879-881. (Dr. Nguyen was an investigator in the EyeTech Study Group). 16. Kramer HJ, Nguyen QD, Curhan G, Hsu CY. “Renal Insufficiency in the Absence of Albuminuria and Retinopathy Among Adults with Type 2 Diabetes Mellitus.” JAMA. 2003; 289: 3273-3277. 17. Early Treatment for Retinopathy of Prematurity Cooperative Group. “Revised Indications for the Treatment of Retinopathy of Prematurity: Results of the Early Treatment for Retinopathy of Prematurity Randomized Trial.” Archives of Ophthalmology. 2003; 121: 1684-1694. (Dr. Nguyen was an investigator in the ET-ROP Cooperative Group). 18. Nguyen QD, Shah SM, Van Anden E, Sung JU, Vitale S, Campochiaro PA. “Supplemental Oxygen Improves Diabetic Macular Edema: A Pilot Study.” Investigative Ophthalmology and Visual Science. 2004; 45: 617-624. 19. Campochiaro PA and the C99-PKC412-003 Study Group. “Reduction of Diabetic Macular Edema by Oral Administration of the Kinase Inhibitor PKC 412.” Investigative Ophthalmology and Visual Science. 2004; 45: 922-931. (Dr. Nguyen was a member of the PKC412 Study Group). 20. Do DV, Shah SM, Sung JU, Haller JA, Nguyen QD. Persistent Diabetic Macular Edema is Associated with Elevated Hemoglobin A1C. American Journal of Ophthalmology. 2005;139: 620-623. 21. Thorne JE, Jabs DA, Qazi FA, Nguyen QD, Kempen JH, Dunn JP. Mycophenolate Mofetil Therapy for Inflammatory Eye Disease. Ophthalmology. 2005; 112: 1472-1477. 22. The Standardization of Uveitis Nomenclature (SUN) Working Group [Dr. Nguyen is a member of the SUN Working Group]. Standardization of Uveitis Nomenclature for Reporting Clinical Data. Results of the First International Workshop. American Journal of Ophthalmology. 2005; 140: 509-516. 23. Campochiaro PA, Nguyen QD, Shah SM, Klein ML, Holz E, Frank RN, Saperstein DA, Gupta A, Stout JT, Macko J, DiBartolomeo R, Wei LL. Adenoviral VectorDelivered Pigment Epithelium-Derived Factor for Neovascular Age-Related Macular Degeneration: Results of a Phase 1 Clinical Trial. Human Gene Therapy. 2006; 17: 167-176. 7 24. Do DV, Nguyen QD, Bressler NM, Schachat AP, Solomon SD, Melia M, Bressler SB. Hemoglobin A1c Awareness among Patients Receiving Eye Care at a Tertiary Ophthalmic Center. American Journal of Ophthalmology. 2006; 141: 951-953. 25. Nguyen QD, Shah SM, Hafiz G, Quinlan E, Sung JU, Chu K, Cedarbaum J, Campochiaro PA, and the CLEAR Investigators. A Phase 1 Trial of Intravenously Administered VEGF Trap for Treatment in Patients with Choroidal Neovascularization due to Age-Related Macular Degeneration. Ophthalmology. 2006; 113: 1522-1530. 26. Nguyen QD, Tatlipinar S, Shah SM, Haller JA, Quinlan E, Sung JU, ZimmerGaller I, Do DV, Campochiaro PA. Vascular Endothelial Growth Factor is a Critical Stimulus for Diabetic Macular Edema. American Journal of Ophthalmology. 2006; 142: 961-969. 27. Shah SM, Tatlipinar S, Quinlan E, Sung JU, Tabandeh H, Nguyen QD, ZimmerGaller I, Symmons RCA, Campochiaro PA. Dynamic and Quantitative Analysis of Choroidal Neovascularization by Fluorescein Angiography. Investigative Ophthalmology and Visual Science. 2006; 47: 5460-5468. 28. Diabetic Retinopathy Clinical Research Network, Browning DJ, Glassman AR, Aiello LP, Beck RW, Brown DM, Fong DS, Bressler NM, Danis RP, Kinyoun JL, Nguyen QD, Bhavsar AR, Gottlieb J, Pieramici DJ, Rauser ME, Apte RS, Lim JI, Miskala PH. Relationship between Optical Coherence Tomography-Measured Central Retinal Thickness and Visual Acuity in Diabetic Macular Edema. Ophthalmology. 2007; 114: 525-536. 29. Tatlipinar S, Shah SM, Campochiaro PA, Nguyen QD. Intraobserver Repeatability of Automated versus Adjusted Optical Coherence Tomography Measurements in Patients with Neovascular Age-Related Macular Degeneration. Ophthalmologica. 2007; 221: 227-232. 30. Gerstenblith A, Thorne JE, Sobrin L, Do DV, Shah SM, Jabs DA, Foster CS, Nguyen QD. Punctate Inner Choroidopathy: Survey Analysis of 77 Persons. Ophthalmology. 2007; 114: 1201-1204. 31. Do DV, Cho M, Nguyen QD, Shah SM, Handa JT, Campochiaro PA, ZimmerGaller I, Sung JU, Haller JA. Impact of Optical Coherence Tomography on Surgical Decision Making for Epiretinal Membranes and Vitreomacular Traction. Transaction of the American Ophthalmological Society. 2007;104: 161-6. 32. Nguyen QD, Shah SM, Hafiz G, Do DV, Haller JA, Pili R, Zimmer-Galler I, Janjua K, Symons RCA, Campochiaro PA. Intravenous Bevacizumab Causes Regression of Choroidal Neovascularization Secondary to Diseases other than Age-Related Macular Degeneration. American Journal of Ophthalmology 2008; 145(2): 257- 8 266. 33. Campochiaro PA, Hafiz G, Shah SM, Nguyen QD, Ying H, Do DV, Quinlan E, Zimmer-Galler I, Haller JA, Solomon SD, Sung JU, Hadi Y, Janjua KA, Jawed N, Choy DF, Arron JR. Ranibizumab for Macular Edema due to Retinal Vein Occlusions: Implication of VEGF as a Critical Stimulator. Molecular Therapy 2008; 16(4):791-799. 34. Ramella-Roman J, Mathews SA, Kandimalla H, Nabili A, Duncan DD, D'Anna SA, Shah SM, Nguyen QD. Measurement of Oxygen Saturation in the Retina with a Spectroscopic Sensitive Multi Aperture Camera. Optics Express 2008; 16 (9): 6170-6182. 35. Chen JK, Khurana RN, Nguyen QD, Do DV. The Incidence of Endophthalmitis following Transconjunctival Sutureless 25- versus 20-gauge Vitrectomy. Eye 2008; June 6. 36. Lim LL, Scarborough JD, Thorne JE, Graham E, Kempen JH, Mackensen F, Nguyen QD, Prabriputaloong T, Read RW, Suhler EB, Schwartz JM, Smith JR. Uveitis in Patients with Autoimmune Hepatitis. Am J Ophthalmol. 2009; Feb;147:332-338. 37. Do DV, Nguyen QD, Shah SM, Browning DJ, Haller JA, Chu K, Yang K, Cedarbaum JM, Vitti RL, Ingerman A, Campochiaro PA. An Exploratory Study of the Safety, Tolerability and Bioactivity of a Single Intravitreal Injection of Vascular Endothelial Growth Factor Trap-Eye in Patients with Diabetic Macular Oedema. Br J Ophthalmol. 2009; Feb;93:144-9. 38. Paganelli F, Cardillo JA, Melo LA, Lucena DR, Silva AA, Oliveira AG, HoflingLima A, Nguyen QD, Kuppermann B, Belfort R, Costa R, Lavinsky D, Skaf M, Lima-Filho AA. A Single Intraoperative Sub-Tenons Capsule Injection of Triamcinolone and Ciprofloxacin in a Controlled-Release System for Cataract Surgery. Invest Ophthalmol Vis Sci. 2009 Feb 21. 39. Nguyen QD, Shah SM, Heier JS, Do DV, Lim J, Boyer D, Abraham P, Campochiaro PA; READ-2 Study Group. Primary End Point (Six Months) Results of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study. Ophthalmology. 2009; 116: 2175-81. 40. Campochiaro PA, Choy DF, Do DV, Hafiz G, Shah SM, Nguyen QD, Rubio R, Arron JR. Monitoring Ocular Drug Therapy by Analysis of Aqueous Samples. Ophthalmology. 2009; 116: 2158-64. 41. Nguyen QD, Shah SM, Browning DJ, Hudson H, Sonkin P, Hariprasad SM, Kaiser P, Slakter JS, Haller J, Do DV, Mieler WF, Chu K, Yang K, Ingerman A, Vitti RL, 9 Berliner AJ, Cedarbaum JM, Campochiaro PA. A Phase I Study of Intravitreal Vascular Endothelial Growth Factor Trap-Eye in Patients with Neovascular AgeRelated Macular Degeneration. Ophthalmology. 2009; 116: 2141-48. 42. The SCORE Study Research Group. A Randomized Trail Comparing the Efficacy and Safety of Intravitreal Triamcinolone with Observation to Treat Vision Loss Associated with Macular Edema Secondary to Central Retinal Vein Occlusion. Archives of Ophthalmology. 2009; 127: 1101-1114. [Dr. Nguyen was a member of the SCORE Study Research Group and was the Principal Investigator for the Wilmer Eye Institute.] 43. The SCORE Study Research Group. A Randomized Trail Comparing the Efficacy and Safety of Intravitreal Triamcinolone with Standard Care to Treat Vision Loss Associated with Macular Edema Secondary to Branch Retinal Vein Occlusion. Archives of Ophthalmology. 2009; 127: 1115-1128. [Dr. Nguyen was a member of the SCORE Study Research Group and was the Principal Investigator for the Wilmer Eye Institute.] 44. Campochiaro PA, Hafiz G, Channa R, Shah SM, Nguyen QD, Ying H, Do DV, Zimmer-Galler I, Solomon DS, Sung JU, Syed B. Antagonism of Vascular Endothelial Growth Factor for Macular Edema Caused by Retinal Vein Occlusions: Two-Year Outcomes. Ophthalmology. 2010. 45. Kaiser PK, Symons RC, Shah SM, Quinlan EJ, Tabandeh H, Do DV, Reisen G, Lockridge JA, Guerciolina R, Nguyen QD for the Sirna-027 Study Investigators. RNAi-Based Treatment for Neovascular Age-Related Macular Degeneration by Sira-027. American Journal of Ophthalmology. 2010;150: 33-39. 46. Campochiaro PA, Hafiz G, Shah SM, Bloom S, Brown DM, Busquets M, Ciulla T, Friner L, Sabates N, Billman K, Kapik B, Green K, Kane F, Nguyen QD, and the FAMOUS Study Group. Sustained Ocular Delivery of Fluocinolone Acetonide by an Intravitreal Insert. Ophthalmology. 2010; 117: 1393-9. [Dr. Nguyen was a member of the FAMOUS Study Group.] 47. Campochiaro PA, Shah SM, Hafiz G, Heier JS, Zimmer-Galler I, Channa R, Nguyen QD, Syed B, Do DV, Lu L, Monk J, Cooke JP, Kengatharan MK, Hsu HH. Topical Mecamylamine for Diabetic Macular Edema. American Journal of Ophthalmology. 2010: 149: 839-51. 48. Shah SM, Nguyen QD, Mir HS, Polito A, Hafiz G, Tatlipinar S, Do DV, Vitale S, Haller J. A Randomized, Double-Masked Controlled Clinical Trial of Sandostatin Long-Acting Release Depot in Patients with Postsurgical Cystoid Macular Edema. Retina. 2010; 30:160-6. 10 49. Kashani AH, Zimmer-Galler I, Shah SM, Dustin L, Do DV, Eliott D, Haller J, Nguyen QD. Retinal Thickness Analysis by Race, Gender, and Age using Stratus OCT. American Journal of Ophthalmology. 2010; 149; 496-502. 50. Cardillo JA, Paganelli F, Melo LA Jr, Silva AA Jr, Pizzolitto AC, Nguyen QD Brazilian Ocular Pharmacology and Pharmaceutical Technology Research Group. Subconjunctival Delivery of Antibiotics in a Controlled-Release System: A Novel Anti-Infective Prophylaxis Approach for Cataract Surgery. Archives of Ophthalmology. 2010; 128: 81-7. [Dr. Nguyen is a member of the Brazilian Ocular Pharmacology and Pharmaceutical Technology Research Group.] 51. Jabs DA, Martin BK, Forman MS, Cytomegalovirus Retinitis and Viral Resistance Research Group. Mortality Associated with Resistant Cytomegalovirus Among Patients with Cytomegalovirus Retinitis and AIDS. Ophthalmology. 2010; 128: 128-132. [Dr. Nguyen was a member of the Cytomegalovirus Retinitis and Viral Resistance Research Group.] Wang J, Ibrahim M, Turkcuoglu P, Hatef E, Khwaja A, Channa R, Do DV, Nguyen QD. Intercellular Adhesion Molecule Inhibitors as Potential Therapy for Refractory Uveitic Macular Edema. Ocular Immunology and Inflammation. 2010. 52. 53. 54. Nguyen QD, Hatef E, Kayen B, Macahilig CP, Ibrahim M, Wang J, Shaikh O, Bodaghi B. A Cross-Sectional Study of the Current Treatment Patterns in Noninfectious Uveitis among Specialists in the United States. Ophthalmology. 2010. Paganellli F, Cardillo JA, Dare AR, Melo LA Jr, Lucena DR, Silva AA Jr, Oliveira AG, Pizzlitto AC, Lavinsky D, Skaf M, Souza-Filho AA, Hofling-Lima AL, Nguyen QD, Kupperman BD, Herrero-Vanrell R, Belfort R Jr, Brazilian Ocular Pharmacology and Pharmaceutical Technology Research Group. Controlled Transscleral Drug Delivery Formulations to the Eye: Establishing New Concepts and Paradigms in Ocular Anti-inflammatory Therapeutics and Antibacterial Prophylaxis. Expert Opinion Drug Delivery, 2010; 7: 955-65. (Dr. Nguyen is a member of the Brazilian Ocular Pharmacology and Pharmaceutical Technology Research Group). 55. Nguyen QD, Shah SM, Khwaja AA, Channa R, Hatef E, Do DV, Boyer D, Heier JS, Abraham P, Thach AB, Lit ES, Foster BS, Kruger E, Dugel P, Chang T, Das A, Ciulla TA, Pollack JS, Lim JI, Eliot D, Campochiaro PA; READ-2 Study Group. Two-Year Outcomes of the Ranibizumab for Edema of the Macula in Diabetes (READ-2) Study. Ophthalmology. 2010; 117: 2146-2151. 56. Hueber W, Patel DD, Dryja T, Wright AM, Koroleva I, Bruin G, Antoni C, Draelos Z, Gold MH; Psoriasis Study Group, Durez P, Tak PP, Gomez-Reino JJ; Rheumatoid Arthritis Study Group, Foster CS, Kim RY, Samson CM, Falk NS, 11 Chu DS, Callanan D, Nguyen QD; Uveitis Study Group, Rose K, Haider A, Di Padova F. Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis. Science and Translational Medicine. 2010; 2:52ra72. 57. De Stefano VS, Abechain JJ, De Almeida LF, Verginassi DM, Rodrigues EB, Freymuller E, Maia M, Magalhaes O Jr, Nguyen QD, Farah ME. Experimental Investigation of Needles, Syringes, and Techniques for Intravitreal Injections. Clinical and Experimental Ophthalmology. 2010. 58. Duncan DD, Lemaillet P, Ibrahim M, Nguyen QD, Hiller M, Ramella-Roman J. Absolute Blood Velocity Measured with a Modified Fundus Camera. Journal of Biomedical Optics. 2010; 15: 056014. 59. Saidha S, Syc SB, Ibrahim M, Eckstein C, Warner CV, Farrell SK, Oakley JD, Durbin MK, Meyer SABalcer LJ, Frohman EM, Newsome S, Ratchford JN, Nguyen QD, Calabresi PA. Primary Retinal Pathology in Multiple Sclerosis as Detected by Optical Coherence Tomography. Brain. 2011; 134: 518-533. 60. Hatef E, Turkcuoglu P, Ibrahim M, Sepah Y, Shulman M, Heo J, Lee JH, Channa R, Khwaja A, Rentiya Z, Shah SM, Do DV, Nguyen QD. Importance of Proper Diagnosis for Management: Multifocal Choroiditis Mimicking Ocular Histoplasmosis Syndrome. Journal of Ophthalmic Inflammation and Infection. 2011; 1: 55-63. 61. Brown DM, Heier JS, Ciulla T, Benz M, Abraham P, Yancopoulos G, Stahl N, Ingerman A, Vitti R, Berliner AJ, Yang K, Nguyen QD. Primary Endpoint Results of a Phase 2 Study of Vascular Endothelial Growth Factor (VEGF) Trap-Eye in Wet Age-Related Macular Degeneration. Ophthalmology. 2011; 118: 1089-1097.. 62. Heier JS, Boyer D, Nguyen QD, Marcus D, Roth DB, Yancopoulos G, Stahl N, Ingerman A, Vitti R, Berliner AJ, Yang K, Brown DM. One-Year Results of CLEAR-IT 2, a Phase2 Study Evaluating VEGF Trap-Eye Dosed on an As-Needed Schedule Following 12-Week Fixed Dosing. Ophthalmology. 2011; 118:10981106. 63. Hatef E, Colantuoni E, Wang J, Ibrahim M, Shulman M, Adhi F, Sepah YJ, Channa R, Khwaja A, Nguyen QD, Do DV. The Relationship between Macular sensitivity and Retinal Thickness in Eyes with Diabetic Macular Edema. American Journal of Ophthalmology. 2011; 152: 400-405. 64. Turkcuoglu P, Chang PY, Rentiya ZS, Channa R, Ibrahim M, Hatef E, Sophie R, Sadaka A, Wang J, Sepah YJ, Do DV, Foster CS, Nguyen QD. Mycophenolate Mofetil and Fundus Autofluorescence in the Management of Recurrent Punctate Inner Choroidopathy. Ocular Immunology and Inflammation. 2011; 19: 286-92. 12 65. Stalmans I, Vandewalle E, Anderson DR, Costa VP, Frenkel RE, Garhofer G, Grunwald J, Gugleta K, Harris A, Hudson C, Januleviciene I, Kagemann L, Kergoat H, Lovasik JV, Lanzl I, Martinez A, Nguyen QD, Plange N, Reitsamer HA, Sehi M, Siesky B, Zeitz O, Orgül S, Schmetterer L. Use of Colour Doppler Imaging in Ocular Blood Flow Research. Acta Ophthalmologica. 2011; 23: 5557-5562. 66. Ibrahim MA, Sepah YJ, Symons RC, Channa R, Hatef E, Khwaja A, Bittencourt M, Heo J, Do DV, Nguyen QD. Spectral- and Time-Domain Optical Coherence Tomography Measurements of Macular Thickness in Normal Eyes and Eyes with Diabetic Macular Edema. Eye (Lond). 2012; 26: 454-462. 67. Sepah YJ, Hatef E, Colantuoni E, Wang J, Shulman M, Adhi FI, Akhtar A, Ibrahim M, Khwaja A, Channa R, Sophie R, Bittencourt M, Heo J, Do DV, Nguyen QD. Macular sensitivity and Fixation Patterns in Normal Eyes and Eyes with Uveitis with and without Macular Edema. Journal of Ophthalmic Inflammation and Infection. 2012;;2:65-73. 68. Channa R, Ibrahim M, Sepah Y, Turkcuoglu P, Lee JH, Khwaja A, Hatef E, Bittencourt M, Heo J, Do DV, Nguyen QD. Characterization of Macular Lesions in Punctate Inner Choroidopathy with Spectral Domain Optical Coherence Tomography. Journal of Ophthalmic Inflammation and Infection. 2012; [Epub] 69. Sheppard JD Jr, Nguyen QD, Usner DW, Comstock TL. Post-cataract Outcomes in Patients with Non-infectious Posterior Uveitis Treated with the Fluocinolone Acetonide Intravitreal Implant. Clinical Ophthalmology. 2012;6:79-85. 70. Nguyen QD, Brown DM, Marcus DM, Boyer DS, Patel S, Feiner L, Gibson A, Sy J, Rundle AC, Hopkins JJ, Rubio RG, Ehrlich JS and the RISE and RIDE Research Group. Ranibizumab for Diabetic Macular Edema – Results from Two Phase III Randomized Trials: RISE and RIDE. Ophthalmology. 2012;119(4):789-801. 71. Liu TY, Ibrahim M, Bittencourt M, Sepah YJ, Do DV, Nguyen QD. Retinal Optical Coherence Tomography Manifestations of Intraocular Lymphoma. . Journal of Ophthalmic Inflammation and Infection. 2012; [Epub] 72. Do DV, Nguyen QD, Boyer D, Schmidt-Erfurth U, Brown DM, Vitti R, Berliner AJ, Gao B, Zeitz O, Ruckert R, Schmelter T, Sandbrink R, Heier JS; DA VINCI Study Group*. One-Year Outcomes of the DA VINCI Study of VEGF Trap-Eye in Eyes with Diabetic Macular Edema. Ophthalmology. 2012; 119:1658-65. 73. Paskowitz DM, Nguyen QD, Gehlbach P, Handa JT, Solomon S, Stark W, Shaikh O, Semba C, Gadek TR, Do DV. Safety, Tolerability, and Bioavailability of Topical SAR 1118, a Novel Antagonist of Lymphocyte Function-Associated Antigen-1: A Phase 1b Study. Eye (Lond). 2012; 26: 944-949. 74. Nguyen QD, Schachar RA, Nduaka CI, Sperling M, Basile AS, Klamerus KJ, ChiBurris K, Yan E, Paggiarino DA, Rosenblatt I, Khan A, Aitchison R, Erlich SS. Phase 1 Dose-Escalation Study of a siRNA Targeting the RTP801 Gene in AgeRelated Macular Degeneration Patients. Eye (Lond). 2012;26:1099-10. 13 75. Nguyen QD, Schachar RA, Nduaka CI, Sperling M, Klamerus KJ, Chi-Burris K, Yan E, Paggiarino DA, Rosenblatt I, Aitchison R, Erlich SS; MONET Clinical Study Group. Evaluation of the siRNA PF-04523655 versus Ranibizumab for the Treatment of Neovascular Age-related Macular Degeneration (MONET Study). Ophthalmology. 2012;119:1867-73. 76. Nguyen QD, Campochiaro PA, Shah SM, Browning DJ, Hudson HL, Sonkin PL, Hariprasad SM, Kaiser PK, Slakter J, Haller JA, Do DV, Mieler W, Chu K, Ingerman A, Vitti R, Berliner AJ, Cedarbaum And The Clear-IT 1 Investigators. Evaluation of Very High- and Very Low-Dose Intravitreal Aflibercept in Patients with Neovascular Age-Related Macular Degeneration. Journal of Ocular Pharmacology and Therapeutics. 2012; 28:581-588. 77. Hatef E, Khwaja A, Rentiya Z, Ibrahim M, Shulman M, Turkcuoglu P, Sepah Y, Wang J, Channa R, Bittencourt M, Akhtar A, Heo J, Do DV, Nguyen QD. Comparison of Time Domain and Spectral Domain Optical Coherence Tomography in Measurement of Macular Thickness in Macular Edema Secondary to Diabetic Retinopathy and Retinal Vein Occlusion. Journal of Ophthalmology; 2012; [Epub]. 78. Campbell JP, Leder HA, Sepah YJ, Gan T, Dunn JP, Hatef E, Cho B, Ibrahim M, Bittencourt M, Channa R, V Do D, Nguyen QD. Wide-field Retinal Imaging in the Management of Noninfectious Posterior Uveitis. American Journal of Ophthalmology. 2012; 154: 908-911.. 79. Saidha S, Sotirchos ES, Ibrahim MA, Crainiceanu CM, Gelfand JM, Sepah YJ, Ratchford JN, Oh J, Seigo MA, Newsome SD, Balcer LJ, Frohman EM, Green AJ, Nguyen QD, Calabresi PA. Microcystic Macular Edema, Thickness of the Inner Nuclear Layer of the Retina, and Disease Characteristics in Multiple Sclerosis: A Retrospective Study. Lancet Neurology. 2012; 11:1021. 80. Do DV, Nguyen QD, Khwaja AA, Channa R, Sepah YJ, Sophie R, Hafiz G, Campochiaro PA for the READ-2 Study Group. Ranibizumab for Edema of the Macula in Diabetes (READ) Study: 3-Year Outcomes and the Need for Prolonged Frequent Treatment. Archives of Ophthalmology. 2012; 1-7. 81. Nguyen QD, Schachar RA, Nduaka CI, Sperling M, Basile AS, Klamerus KJ, ChiBurris K, Yan E, Paggiarino DA, Rosenblatt I, Aitchison R, Erlich SS for the DEGAS Clinical Study Group. Dose-Ranging Evaluation of Intravitreal siRNA PF-04523655 for Diabetic Macular edema (the DEGAS study). Investigative Ophthalmology and Visual Sciences. 2012; 53:7666-74. 82. Heier JS, Brown DM, Chong V, Korobelnik JF, Kaiser PK, Nguyen QD, Kirchhof B, Ho A, Ogura Y, Yancopoulos GD, Stahl N, Vitti R, Berliner AJ, Soo Y, 14 Anderesi M, Groetzbach G, Sommerauer B, Sandbrink R, Simader C, SchmidtErfurth U for the VIEW 1 and VIEW 2 Study Groups. Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-Related Macular Degeneration. Ophthalmology. 2012; 119: 2537-2548. 83. Do DV, Greenwald L, Ibrahim M, Sepah Y, Nguyen QD. Choroidal Neovascularization Regression on Fluorescein Angiography after VEGF Blockade. Case Reports in Ophthalmology. 2012; 3: 384-388. 84. Campochiaro PA, Nguyen QD, Hafiz G, Bloom S, Brown DM, Busquets M, Ciulla T, Feiner L, Sabates N, Billman K, Kapik B, Green K, Kane FE for the FAMOUS Study Group. Aqueous Levels of Fluocinolone Acetonide after Administration of Fluocinolone Acetonide Inserts or Fluocinolone Acetonide Implants. Ophthalmology. 2012 85. Oh J, Sotirchos ES, Saidha S, Ibrahim M, Sepah Y, Nguyen QD, Calabresi PA. In Vivo Demonstration of Homonymous Hemimacular Loss of Retinal Ganglion Cells due to a Thalamic Lesion using Optical Coherence Tomography. JAMA Neurology. 2013; 70: 410-411. 86. Ibrahim MA, Do DV, Sepah YJ, Shah SM, Van Anden E, Hafiz G, Donahue JK, Rivers R, Balkissoon J, Handa JT, Campochiaro PA, Nguyen QD. Vascular Disrupting Agent for Neovascular Age-Related Macular Degeneration: A Pilot Study of the Safety and Efficacy of Intravenous Combretastatin A-4 Phosphate. BMC Pharmacology and Toxicology. 2013; 14:7. 87. Yohannan J, Bittencourt M, Sepah YJ, Hatef E, Sophie R, Moradi A, Liu H, Ibrahim M, Do DV, Coulantuoni E, Nguyen QD. Association of Retinal Sensitivity to Integrity of Photoreceptor Inner/Outer Segment Junction in Patients with Diabetic Macular Edema. Ophthalmology. 2013. 88. Leder HA, Campbell JP, Sepah YJ, Gan T, Dunn JP, Hatef E, Cho B, Ibrahim M, Bittencourt M, Channa R, Do DV, Nguyen QD. Ultra-Wide-Field Retinal Imaging in the Management of Non-Infectious Retinal Vasculitis. Journal of Ophthalmic Inflammation and Infection. 2013. 89. Nguyen QD, Ibrahim MA, Watters A, Bittencourt M, Yohannan J, Sepah YJ, Dunn JP, Naor J, Shams N, Shaikh O, Leder HA, Do DV. Ocular Tolerability and Efficacy of Intravitreal and Subconjunctival Injections of Sirolimus in Patients with Non-Infectious Uveitis: Primary 6-Month Results of the SAVE Study. Journal of Ophthalmic Inflammation and Infection. 2013. 90. Sotirchos ES, Saidha S, Byraiah G, Mealy MA, Ibrahim MA, Sepah YJ, Newsome SD, Ratchford JN, Frohman EM, Balcer LJ, Crainiceanu CM, Nguyen QD, Levy 15 M, Calabresi PA. In-Vivo Identification of Morphologic Retinal Abnormalities in Neuromyelitis Optica. Neurology. 2013. 91. Do DV, Nguyen QD, Khwaja AA, Channa R, Sepah YJ, Sophie R, Hafiz G, Campochiaro PA, and the READ-2 Study Group. Ranibizumab for Edema of the mAcula in Diabetes Study: 3-year Outcomes and the Need for Prolonged Frequent Treatment. JAMA Archives of Ophthalmology. 2013;131:139-45. 92. Burkholder BM, Wang J, Dunn JP, Nguyen QD, Thorne JE. Postoperative Outcomes after Fluocinolone Acetonide Implant Surgery in Patients with Birdshot Chorioretinitis and Other Types of Posterior and Panuveitis. Retina. 2013. EDUCATIONAL PUBLICATIONS Invited Peer-Reviewed Review Articles 1. Nguyen QD, Foster CS. “Cicatricial Pemphigoid: Diagnosis and Treatment.” International Ophthalmology Clinics. Winter 1996; 36 (1): 41-60. 2. Nguyen QD, Foster CS. “Systemic Lupus Erythematosus and the Eye.” International Ophthalmology Clinics. Winter 1998; 38 (1): 33-60. 3. Nguyen QD, Foster CS. “Saving the Vision of Children with Juvenile Rheumatoid Arthritis-Associated Uveitis.” JAMA. 1998; 280: 1133-1136. 4. Nguyen QD, Foster CS. “Scleral Homograft in the Management of Necrotizing Scleritis.” International Ophthalmology Clinics. Winter 1999; 39: 109-131. 5. Nguyen QD, Tawansy K, Hirose T. “Recent Advances in Retinopathy of Prematurity.” International Ophthalmology Clinics. Fall 2001; 41: 129-151. 6. Kruger EF, Nguyen QD, Ramos-Lopez M, Lashkari K. “Proliferative Vitreoretinopathy after Trauma.” International Ophthalmology Clinics. 2002; 42: 129-143. 7. Nguyen QD, Do DV. “Retinal Vasculitis: Current Concepts in Diagnosis and Management.” Contemporary Ophthalmology. 2002; 1 (12): 1-16. 8. Nguyen QD, Do DV. “Diabetic Retinopathy: An Overview for NonOphthalmologists.” Advanced Studies in Medicine. 2003; 3: 214-222. 9. Nguyen QD, Callanan D, Dugel P, Godfrey DG, Goldstein DA, Wilensky JT. Treating Chronic Noninfectious Posterior Segment Uveitis: the Impact of Cumulative Damage – Proceedings of an Expert Panel Roundtable Discussion. 16 Retina. 2006; October: Supplement 1-16. 10. Brumm M, Nguyen QD. Fluocinolone Acetonide Intravitreal Sustained Release Device - A New Addition to the Armamentarium of Uveitic Management. International Journal of Nanomedicine. 2007; 2: 55-64. 11. Khurana RN, Do DV, Nguyen QD. Anti-VEGF Approach for Diabetic Macular Edema. International Ophthalmology Clinics. 2009; 49(2):109-19. 12. Gomes Bittencourt M, Sepah YJ, Do DV, Agbedia O, Akhtar A, Liu H, Akhlaq A, Annam R, Ibrahim M, Nguyen QD. New Treatment Options for Non-Infectious Uveitis. Developmental Ophthalmology. 2012; 51:134-61. 13. Heo J, Sepah YJ, Yohannan J, Renner M, Akhtar A, Gregory A, Shulman M, Do DV, Nguyen QD. The Role of Biologic Agents in the Management of Non-Infectious Uveitis. Expert Opinion in Biological Therapy. 2012;12:995-1008. Editorials 1. Pan RJD and Nguyen QD. Preparing for Practice in the New Health Care System. JAMA. 1996; 276 (9): 666. 2. Kashani AH, Zimmer-Galler IE, Shah SM, Dustin L, Do DV, Eliott, Haller JA, Nguyen QD. Retinal Thickness Analysis by Race, Gneder, and Age Using Stratus OCT. American Journal of Ophthalmology. 2010; 150:288-290. Peer-Reviewed Case Reports 1. Uy HS, Nguyen QD, Durand ML, Paton B, Foster CS. “Infectious Crystalline Keratopathy and Endophthalmitis Secondary to Mycobacterium abscessus in a Monocular Patient with Stevens-Johnson Syndrome.” American Journal of Ophthalmology. 1999; 127: 209-210. 2. Do DV, Rismondo V, Nguyen QD. “Reversible Cortical Blindness in Preeclampsia.” American Journal of Ophthalmology. 2002; 134: 916-918. 3. Margalit E, Sung JU, Do DV, Yohay K, Nguyen QD. “Panuveitis in Association with Pseudotumor Cerebri.” Journal of Child Neurology. 2005; 20: 234-236. 4. Nguyen QD, Shah SM, Tatlipinar S, Do DV, Van Anden E, Campochiaro PA. Bevacizumab Suppresses Choroidal Neovascularization Due to Pathologic Myopia. British Journal of Ophthalmology. 2005; 89: 1368-1370. 5. Tatlipinar S, Shah SM, Nguyen QD. OCT Features of Sub-Internal Limiting Membrane Hemorrhage and Preretinal Membrane in Valsalva Retinopathy. 17 Canadian Journal of Ophthalmology. 2007; 42: 129-130. 6. Pérez-Alvarez MJ, González-Guijarro J, Adán-Civera A, Moreno-López M, Williams DF, Nguyen QD. Diagnostic and Therapeutic Challenges: Retinitis. Retina. 2007; 27: 509-513. 7. Patel S, Petrarca R, Shah SM, Zimmer-Galler I, Do DV, Nguyen QD. Atypical Bartonella hensalae Chorioretinitis in an Immunocompromised Patient. Ocular Immunology and Inflammation. 2008; 16(1): 45-49. 8. Park SS, Holz HA, Ravage ZB, Merrill PT, Nguyen QD. Diagnostic and Therapeutic Challenges: Chorioretinitis and Panuveitis. Retina. 2008; 27: 660-664. 9. Marcus EI, Do DV, Shah SM, Biswas J, Levinson R, Nguyen QD. Diagnostic and Therapeutic Challenges: Granulomatous Panuveitis. Retina. 2008; 28: 1544-1549. 10. Patel S, Petrarca R, Shah SM, Zimmer-Galler I, Do DV, Nguyen QD. Atypical Bartonella hensalae Chorioretinitis in an Immunocompromised Patient. Ocular Immunology and Inflammation. 2008; 16(1): 45-49. 11. Park SS, Holz HA, Ravage ZB, Merrill PT, Nguyen QD. Diagnostic and Therapeutic Challenges: Chorioretinitis and Panuveitis. Retina. 2008; 27: 660-664. 12. Marcus EI, Do DV, Shah SM, Biswas J, Levinson R, Nguyen QD. Diagnostic and Therapeutic Challenges: Granulomatous Panuveitis. Retina. 2008; 28: 1544-1549. 13. Channa R, Khurana RN, Speicher MA, Shah SM, Do D, Levinson R, Goldstein DA, Nguyen QD. Diagnostic and Therapeutic Challenges: The Case of the Man from Sierra Leone. Retina. 2009; 29(7):1045-51. 14. Sabet-Peyman EJ, Nguyen QD, Do DV. Cystoid Macular Edema Responds to Intravitreal Triamcinolone and Rebounds after Intravitreal Bevacizumab. Ophthalmic Surgery and Lasers Imaging. 2009; 40(4):413-5. 15. Sabet-Peyman EJ, Eberhart CG, Janjua K, Shah SM, Do DV, Nguyen QD. Persistent Intermediate Uveitis Associated with Latent Manifestation of Facial Larage B-Cell Non-Hodgkin Lymphoma. Ocular Immunology and Inflammation. 2009; 17: 322-24. 16. Khurana RN, Leder HA, Nguyen QD, Do DV. Enterococcus casseliflavus Endophthalmitis Associated with a Horse Tail Injury. Archives of Ophthalmology. 2009; 127: 1551-52 18 17. Fallano KA, Ibrahim M, Nguyen QD, Do DV. Progressive Changes from Idiopathic Macular Telangiectasia Seen with Spectral Domain Optical Coherence Tomography. Canadian Journal of Ophthalmology. 2010; 45: 1-2. 18. Kim BJ, Do DV, Arevalo F, Van Gelder RN, Nguyen QD. Diagnostic and Therapeutic Challenges: Acute Onset Panuveitis. Retina. 2010; 30: 364-8. 19. Hatef E, Wang J, Ibrahim M, Turkcuoglu P, Khwaja A, Channa R, Suan EP, Dibernado C, Sepah YJ, Do DV, Nguyen QD. Nodular Sclerochoroidopathy Simulating Choroidal Malignancy. Ophthalmic Surgery Lasers Imaging. 2010; 41. 20. Hatef E, Ibrahim M, Nguyen QD, Do DV, Davis MJ, Rezaei KA, Kovach JL. Diagnostic and Therapeutic Challenges. Retina. 2011 March. 21. Vance SK, Freund KB, Wenick AS, Nguyen QD, Holland GN, Kreiger AE. Diagnostic and Therapeutic Challenges. Retina. 2011 April. 22. Le-Nguyen XT, Lee TK, Do DV, Sepah YJ, Nguyen QD, Rao NA, VasconcelosSantos DV, Goldstein DA. Diagnostic and Therapeutic Challenges. Retina. 2011 June. 23. Chen LY, Kesen MR, Ghafourian A, Nguyen QD, Eberhart CG, Do DV. Isolated Endogenous Nocardia Endophthalmitis after Immunosuppression. Journal of Ophthalmic Inflammation and Infection. 2012; [Epub] 24. Yohannan J, Channa R, Dibernardo CW, Zimmer-Galler IE, Ibrahim M, Sepah YJ, Bittencourt M, Do DV, Nguyen QD. Sclerochoroidal Calcifications Imaged Using Enhances Depth Imaging Optical Coherence Tomography. Ocular Immunology and Inflammation. 2012; 20:190-192. 25. Wenick AS, Paskowitz DM, Tauqir MZ, Nguyen QD. Choroidal Neovascularization and Bevacizumab Therapy in Aicardi Syndrome. Graefes Arch Clinical and Experimental Ophthalmology. 2012; [Epub]. 26. Tauqir MZ, Shulman M, Bittencourt M, Sepah YJ, Ibrahim M, Do DV, Nguyen QD, Foster CS, Vora RA, Albini TA. Diagnostic and Therapeutic Challenges: Retinal Vasculitis. Retina. 2013. Letters and Correspondence 1. Nguyen QD, Shah SM, Campochiaro PA. Oxygen and Diabetic Retinopathy. Investigative Ophthalmology and Visual Science Online, January, 2005. 19 2. Do DV, Nguyen QD. Reply Letter Regarding Persistent Diabetic Macular Edema is Associated with Elevated Hemoglobin A1C. American Journal of Ophthalmology; 140: 961, 2005. 3. Kashani AH, Zimmer-Galler I, Shah SM, Do DV, Nguyen QD, Dustin L, Eliott D, Haller J. Reply Letter Regarding Retinal Thickness Analysis by Race, Gender, and Age using Stratus OCT. American Journal of Ophthalmology. 2010; 150; 288290. 4. Brown DM, Nguyen QD, Ehrlich JS for the RISE and RIDE Research Group. Ranibizumab for Diabetic Macular Edema. Author Reply. Ophthalmology. 2013; 120: 221-222. Book Chapters 1. Nguyen QD. “Youth from Every Quarter” in Transitions, Exeter Remembered, 1961-1987. B Eggers, P Greer, C Robinson, and D Weber, Editors. Phillips Exeter Academy Press, Exeter, New Hampshire, 1990. 2. Foster CS and Nguyen QD. “Adamantiades-Behcet’s Disease” in Principles and Practice of Ophthalmology, Second Edition. DM Albert and FA Jakobiec, Editors. W.B. Saunders, Philadelphia, Pennsylvania 1999. 3. Nguyen QD and Foster CS. “Tectonic Procedures” in Ophthalmic Surgery: Principles and Techniques. DM Albert, Editor. Blackwell Science, Malden, Massachusetts, 1999. 4. Nguyen QD and Foster CS. “The Red Eye” in Pediatric Ophthalmology. PF Gallin, Editor. Thieme, New York, New York, 2000. 5. Jabs DA and Nguyen QD. “Sarcoidosis” in Retina, Third Edition. SJ Ryan, Editor. C.V. Mosby, St. Louis, Missouri, 2000. 6. Jabs DA and Nguyen QD. “Toxoplasmosis” in Retina, Third Edition. SJ Ryan, Editor. C.V. Mosby, St. Louis, Missouri, 2000. 7. Nguyen QD. “Traumatic Uveitis” in Diagnosis and Treatment of Uveitis. CS Foster and A Vitale, Editors. W.B. Saunders, Philadelphia, Pennsylvania, 2002. 8. Nguyen QD, Do DV. “Areas of Fundus Whitening: Geographic Whitening” in Clinical Pathways in Vitreoretinal Disease. ME Hartnett and S Steidl, Editors. Thieme Medical Publishers, New York, New York, 2003. 9. Nguyen QD. “Pathology and Pathogenesis of Scleritis and Sclerokeratitis” in The Sclera and Systemic Disorders. PG Watson, BL Hazleman, CE Pavesio, WR 20 Green, Editors. Butterworth and Heineman, London, 2004. (Dr. Nguyen was one of the 6 contributors to the textbook). 10. Nguyen QD. “Scleritis in Relation to Connective Tissue Disorders” in The Sclera and Systemic Disorders. Second Edition. PG Watson, BL Hazleman, CE Pavesio, WR Green, Editors. Butterworth and Heineman, London, 2004. (Dr. Nguyen was one of the 6 contributors to the textbook). 11. Nguyen QD. “Tectonic Procedures” in Clinical Atlas of Procedures in Ophthalmic Surgery. DM Albert and M Lucarelli, Editors. AMA Press, Chicago, Illinois, 2004. 12. Nguyen QD and Do DV. “Uveitis Associated with Juvenile Idiopathic Arthritis” in Current Ocular Therapy, Sixth Edition. Roy and Fraunfelder, Editors. Elsevier, Ltd., United Kingdom, 2007. 13. Do DV, Nguyen QD, Shah MS, Haller JA. “Ranibizumab for the Treatment of Diabetic Macular Edema” in Retinal Vascular Diseases, 1st Edition. Joussen, Editor. Elsevier, Ltd. United Kingdom, 2008. 14. Do DV, Nguyen QD, Haller JA. “Retinal Arterial Macroaneurysms” in Principles and Practice of Ophthalmology, 3rd Edition. Albert and Miller, Editors. Elsevier, Ltd. United Kingdom, 2008. 15. Campbell JP, Do DV, Nguyen QD. “Macular Edema Associated with Ocular Inflammatory Diseases” in Macular Surgery, 2nd Edition. Quiroz-Mercado and Kerrison, Editors. Wolters Kluwer, 2011. 16.. Ibrahim M, Channa R, Nguyen QD. “Anti-Angiogenesis Drugs for Neovascular AMD Currently in Clinical Trials” in Therapy of Ocular Angiogenesis: Principles and Practice. Das and Friberg, Editors. Lippincott Williams and Wilkins, 2011. 17. Kim BJ, Do DV, Nguyen QD. “Ranibizumab and Other VEGF Antagonists for Diabetic Macular Edema” in Visual Dysfunction in Diabetes. Tombran-Tink, Barnstable, and Gardner, Editors. Human Press, 2012. Books Nguyen QD, Rodrigues EB, Farah M, Mieler W, Editors. Retinal Pharmacotherapy, 1st Edition. Elsevier, Ltd. United Kingdom, 2010. TEACHING 21 Classroom Instruction Lecture Titles 1. Basic Eye Exam The lecture (90 minutes in length) is given 6 times a year at the Wilmer Eye Institute, as part of the Introduction to Ophthalmology Clerkship for medical students (mainly second and third year students). Role: Principal Instructor 2. Diagnosis and Management of Retinal Detachment The lecture (120 minutes in length), which is delivered as a seminar with maximum participation from the students, is given 4-5 times a year at the Wilmer Eye Institute, as part of the Advanced Clerkship in Ophthalmology for medical students (mainly third and fourth year students). Role: Principal Instructor 3. Diagnosis and Management of Retinal Vasculitis The lecture (60 minutes in length) is given annually to the residents at the Wilmer Eye Institute as part of the lecture series in diseases of the retina and vitreous. Residents from all years attend the lecture. Role: Principal Instructor 4. White Dot Syndromes: How Do You Tell Them Apart or Can You? The lecture (60 minutes in length) is given annually to the residents at the Wilmer Eye Institute as part of the lecture series in diseases of the retina and vitreous. Residents from all years attend the lecture. Role: Principal Instructor Clinical Instruction 1. Teaching of Fellows Trained in Medical and Surgical Diseases of the Retina and Vitreous, Retina Division, Wilmer Eye Institute Supervising and teaching fellows three times a week when they rotate with me in my clinics and participate with me in surgery. 2. Teaching of Residents in Ophthalmology on Diseases of the Retina and Vitreous, and Uveitis, Wilmer Eye Institute Teaching residents weekly when they rotate with me in my clinics and participate with me in surgery. MENTORING 22 Mentoring of Johns Hopkins University and Other University Undergraduate and Medical Students Serving as faculty mentor to undergraduate and medical students who are interested in pursuing a career in ophthalmology. In this capacity, I work very closely with the students to advise them on their courses, on their residency application process, as well as to provide them with opportunities for research activities. I have had the opportunity to mentor several undergraduate and medical students during the past several years. Advisees/Mentees Date Name Degree Present Position 2005-2006 Amir Kashani MD 2006-2007 2006-2007 2006-2008 Adam Gerstenblith MD Matthew Brumm MD Peter Campbell MD 2007-2009 Kashif Janjua MD 2008-2012 Jordan Ambrose BS 2009-2010 Matthew Shulman BS 2008-2010 Aymen Rashid BS 2009- Hyun Soo Jang 2009- Jithin Yohannan BS 2010- Abeer Akhtar BS Fellow in Retina, Associated Retinal Consultants, Michigan Fellow in Retina, Wills Eye Institute Practicing Ophthalmologist, Michigan Resident in Ophthalmology, Wilmer Eye Institute Attending in Internal Medicine University of Medicine and Dentistry of New Jersey Medical Student, University of Maryland Class of 2012 Medical Student, University of Maryland Class of 2014 Medical Student, Johns Hopkins University Class of 2014 Undergraduate Student, Johns Hopkins University MPH Student, Johns Hopkins School of Public Health Class of 2012 Medical Student, Johns Hopkins University Class of 2013 Medical Student, Harvard Medical Student Class of 2016 Current Post-Doctoral Research Fellows (who are being mentored directly by me) Owhofasa Agbedia, MD, MPH (Ibadan, Nigeria) Rachel Annam, MD, MPH (Abuja, Nigeria) Millena Bittencourt, MD (Sao Paulo, Brazil) Daniel Ferraz, MD (Sao Paulo, Brazil) Mostafa Hanout, MD (Cairo, Egypt) Mohamed Ibrahim, MD (Cairo, Egypt) 23 Hongting Liu, MD (Beijing, China) Ahmadreza Moradi, MD (Tehran, Iran) Yasir Sepah, MD (Peshawar, Pakistan) Past Post-Doctoral Research Fellows (who were mentored by me at the Wilmer Eye Institute) Roomasa Channa, MD: Residency in Ophthalmology, Wilmer Eye Institute, Johns Hopkins University School of Medicine starting July 2012 Elham Haftef, MD: Residency in Preventive Medicine, Johns Hopkins University School of Medicine and School of Public Health starting July 2012 Afsheen Khwaja, MD: Associate Medical Director, Santen Pharmaceuticals, Inc. Jangwon Heo, MD: Assistant Professor of Ophthalmology, Seoul National University, Seoul, Korea Peykan Turkcuoglu, MD: Associate Professor of Ophthalmology, Inonu University School of Medicine, Malatya, Turkey Jianmin Wang, MD: Associate Professor of Ophthalmology, the Second Hospital of Hebei Medical University, Hebei, China EDUCATIONAL PROGRAM BUILDING AND LEADERSHIP I have completed the following professional development seminars sponsored by the Office of Faculty Development of Johns Hopkins University in an effort to improve my leadership skills and abilities, which I believe will be beneficial for my academic career as well as for my interaction and collaboration with colleagues and staff members. 1. Hiring Staff: Tips and Tools for Faculty 2. Speak Like a Pro 3. How to Succeed in Managing Your Staff and Working with Your Colleagues CLINICAL ACTIVITIES MEDICAL LICENSURE 1994 1997 National Board of Medical Examiners Massachusetts Medical License number 153489 24 1997 1998 1998 1998 2002 2013 United States DEA License number BN 5327487 District of Columbia Medical License number MD 30860 Maryland Medical License number D 0053275 Virginia Medical License number 0101057360 Diplomate of the American Board of Ophthalmology Nebraska Medical License number 27206 CLINICAL RESEARCH ACTIVITIES: PARTICIPATION IN CLINICAL TRIALS 1. Principal Investigator Supplemental Inspired Oxygen for Hypoxia-Mediated Retinal Diseases Sponsored by the National Eye Institute 2001-2006 2. Co-Investigator A Phase 2 Randomized, Multicenter Controlled Trial of Octreotide Acetate (Sandostatin LAR) in the Treatment of Diabetic Retinopathy Sponsored by Novartis, Inc. 2001-2003 3. Co-Investigator A Multicenter, Randomized, Double2001-2004 Masked, Placebo-Controlled Parallel-Group Dose Finding Phase II Study of PKC412 (50, 100, 150 mg/day) in Patients with Diabetic Macular Edema Sponsored by CIBA Vision/Novartis, Inc. 4. Co-Investigator A Phase 2/3 Randomized, Double Masked 2002-2004 Controlled, Multi-Center Comparative Trial to Establish the Safety and Efficacy of Intravitreal EYE001 (Anti-VEGF Pegylated Aptamer) in Patients with Exudative AgeRelated Macular Degeneration Sponsored by EyeTech, Inc. 5. Co-Investigator A Phase 2 Randomized, Multicenter, 2002-2003 Dose-Ranging, Controlled, Parallel-Group Trial to Assess the Safety and Efficacy of Dexamethasone Posterior Drug Delivery System (DEX PS DDS) in the Treatment of Persistent Macular Edema Sponsored by Oculex Pharmaceuticals, Inc. 6. Co-Investigator Early Treatment for Retinopathy of Prematurity Sponsored by the National Eye Institute 2002-2004 25 7. Co-Investigator GV-003.001 An Open-Label, Phase I, Single Administration, Dose-Escalation Study of AdGV PEDF.11D in Neovascular Age-Related Macular Degeneration Sponsored by GenVec, Inc. 2002-2006 8. Principal Investigator An Open Label, Pilot (Phase I/II), Dose2003-2005 Escalation Safety and Tolerability Study of Combretastatin A4 Phosphate in Patients with Neovascular Age-Related Macular Degeneration Sponsored by Foundation Fighting Blindness, Inc. 9. Co-Investigator 10. Principal Investigator An Exploratory Study of the Safety, 2004-2006 Tolerability, and Biological Activity of Intravenously Administered VEGF Trap in Patients with Neovascular Age-Related Macular Degeneration Sponsored by Regeneron, Inc. 11. Principal Investigator The Standard Care versus Corticosteroid 2004-2009 for Retinal Vein Occlusion (SCORE) Study Sponsored by the National Eye Institute 12. Principal Investigator An Exploratory Study of the Safety, 2004-2006 Tolerability, and Biological Activity of Intravenously Administered VEGF Trap in Patients with Diabetic Macular Edema Sponsored by Regeneron, Inc. 13. Principal Investigator A Pilot, Open-Label, Dose-Escalation Study 2004-2006 of the Safety, Tolerability, and Efficacy of Multiple Intravitreal Injections of Ranibizumab in Subjects with Macular Edema Secondary to Diabetes Mellitus Sponsored by Juvenile Diabetes Research Foundation A Phase III, Multicenter, Randomized, 2003-2006 Double-Masked, Sham Injection-Controlled Study of the Efficacy and Safety of rhuFab V2 (Ranibizumab) in Subjects with Minimally Classic or Occult Subfoveal Neovascular AgeRelated Macular Degeneration Sponsored by Genentech, Inc. & Novartis AG 26 14. Principal Investigator A Randomized, Double-Masked, Parallel 2005-2006 Group Multicenter, Dose Ranging Pilot Study of Denufosol Tetrasodium (INS37217) Intravitreal Injection in Subjects with Uveitis Associated Cystoid Macular Edema Sponsored by Inspire Pharmaceuticals, Inc. 15. Principal Investigator An Exploratory Study of the Safety, 2005-2012 Tolerability, and Biological Effect of Intravitreal Administration of VEGF Trap in Patients with Neovascular Age-Related Macular Degeneration Sponsored by Regeneron, Inc. 16. Principal Investigator Intravenous Bevacizumab for Choroidal Neovascularization not Secondary to AgeRelated Macular Degeneration Sponsored by Retina Research Fund 17. Co-Investigator A Randomized, Double-Masked, Parallel 2006-2011 Group, Multi-Center, Dose-Finding Comparison of the Safety and Efficacy of ASI-001A 0.5 µg/day and ASI-001B 0.2 µg/day Fluocinolone Acetonide Intravitreal Inserts to Sham Injection in Subjects with Diabetic Macular Edema Sponsored by Alimera, Inc. 18. Co-Investigator A 3-Year, Phase 3, Multicenter, Masked, 2006Randomized, Sham-Controlled Trial to Assess the Safety and Efficacy of 700 µg and 350 µg Dexamethasone Posterior Segment Drug Delivery System (DEX PS DDS) Applicator System in the Treatment of Patients with Diabetic Macular Edema Sponsored by Allergan, Inc. 19. Co-Investigator A Randomized, Open-Label Study of the 2006-2009 Safety, Tolerability, and Bioactivity of Intravitreal Ranibizumab in Subjects with Macular Edema Secondary to Retinal Vein Occlusions Sponsored by Genentech, Inc. 20. Co-Investigator A Multi-Center, Randomized, Double2006-2008 Masked, Placebo Controlled, Sequential Dose Response Study of Intravitreally Administered Plasmin for the Creation of a Posterior Vitreous Detachment (PVD) Sponsored by Bausch and Lomb, Inc. 2005-2007 27 21. Co-Investigator A Randomized, Double-Masked, Multi2007-2009 Center Phase I/II study of the Safety of PTK787 Administered in Conjunction with Photodynamic Therapy with Visudyne® to Patients with Predominantly Classic, Minimally Classic or Occult with no Classic Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration Sponsored by Novartis, Inc. 22. Co-Investigator A Multi-Center, Randomized Trial of 2007Lutein, Zeaxanthin, and Omega-3 Fatty Acids in AgeRelated Macular Degeneration Sponsored by the National Eye Institute 23. Co-Investigator Phase 2 Study of the Safety and Bioactivity 2007-2009 of Topical Ocular Mecamylamine for the Treatment of Diabetic Macular Edema Sponsored by the Juvenile Diabetes Research Foundation and Comentis, Inc. 24. Principal Investigator A Double-Masked, Placebo-Controlled, 2007-2009 Parallel-Group, Multi-Center, Dose-Ranging Study to Assess the Efficacy and safety of LX-211 as Therapy in Subjects with Active Sight Threatening Non-Infectious Anterior Uveitis; Clinically Quiescent Sight Threatening, Non-Infectious Intermediate-, Anterior and Intermediate-, Posterior-, or Pan-Uveitis; or Active Sight Threatening, Non-Infectious Anterior Uveitis Sponsored by Lux Biosciences, Inc. 25. Principal Investigator A Randomized, Double Masked, Active 2007-2012 Controlled Phase III Study of the Efficacy, Safety, and Tolerability of Repeated Doses of Intravitreal VEGF Trap in Subjects with Neovascular Age-Related Macular Degeneration Sponsored by Regeneron Pharmaceuticals, Inc. 26. Principal Investigator A Phase 1 Open-Label, Dose Escalation 2008-2010 Trial of REDD14NP in Patients with Choroidal Neovascularization Secondary to Exudative Macular Degeneration Sponsored by Pfizer, Inc. 27. Principal Investigator An Open-Label Study to Assess the Effect of Two Doses of AIN457 in Patients with 2008-2010 28 Non-Infectious Uveitis Sponsored by Novartis, Inc. 28. Principal Investigator A Multicenter, Single Sequence, Open-Label 2009-2011 Study to Assess the Tolerability, Safety and Efficacy of AEB071 in the Treatment of Patients with Macular Edema associated with Non-Infectious Intermediate Uveitis, Posterior Uveitis, or Panuveitis Sponsored by Novartis, Inc. 29. Principal Investigator Sirolimus as Novel Approach for Uveitis: 2009the SAVE Study Sponsored by Uveitis Research Fund at Wilmer, MacuSight, Inc., and Santen, Inc. 30. Principal Investigator A Phase 2, Randomized, Double-Masked, 2010-2012 Controlled Study to Establish the Safety and Efficacy of E10030 (Anti-PDGF Pegylated Aptamer) Given in Combination with Lucentis® in Subjects with Neovascular Age-Related Macular Degeneration Sponsored by Ophthotech, Inc. 31. Principal Investigator A Multicenter Study of the Efficacy and Safety of the HumanAnti-TNF Monoclonal Antibody Adalimumab in Subjects Requiring High Dose Corticosteroids for Active Non-Infectious Intermediate, Posterior, or pan-Uveitis Sponsored by Abbott, Inc. 32. Principal Investigator A Multi-Center, Double-Masked, Parallel 2011Group, Placebo Controlled Study to Assess the Efficacy and Safety of Voclosporin as Therapy in Subjects with Active Non-Infectious Intermediate, Posterior, or Pan-Uveitis Sponsored by Lux Biosciences, Inc. 33. Principal Investigator MD7114987, An Open-label, Phase 2a Study 2011-2012 to Evaluate Pazopanib Eye Drops Administered for 12 weeks To Evaluate Patients with Neovascular Age-related Macular Degeneration Sponsored by Glaxo-Smith-Kline, Inc. 34. Principal Investigator A Phase 2, Multi-center, Randomized, 2011-2012 Placebo-controlled, Parallel-Group Study to Investigate the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of GSK933776 in Adult Patients with Geographic Atrophy (GA) secondary to Age-related Macular 29 Degeneration (AMD). Sponsored by Glaxo-Smith-Kline, Inc. ORGANIZATIONAL ACTIVITIES INSTITUTIONAL ADMINISTRATIVE APPOINTMENTS Johns Hopkins University School of Medicine 2003-2005 Member, JH SOM Medical School Council Committee on Advancement of Junior Faculty – chaired by Patricia Thomas, MD, Associate Dean for Curriculum. This Committee worked with chairs of clinical departments to determine the mechanisms and infrastructure available in each department to help the mentoring and promotion of Assistant Professorship to Associate Professorship. 2003- Member, Admissions Committee for the School of Medicine – chaired by James Weiss, MD, Professor of Medicine and Associate Dean for Admission. This Committee interviews student applicants to JH School of Medicine (SOM) and meets in the Fall, Winter, and early Spring to select the best possible students for the medical school. 2006- Member, Educational Policy and Curriculum Committee (EPCC) – chaired by David Nichols, MD, Vice Dean for Education. This Committee is made up of leaders from core basic science courses and clinical clerkships. It oversees and governs the policy and conducts of courses and curriculum for all medical students. My role as a member of the EPCC Committee, with particular focus on Ophthalmology, requires 5% effort, which is provided by the SOM. 2006-2010 Member, Student Assessment and Program Evaluation (SAPE) Committee – chaired by Pamela Lipsett, MD, Professor of Surgery. This Committee reviews and evaluates each core basic course and clinical clerkship in the SOM, based on reports and interviews with the course directors, chairperson of the department, as well as medical students. The SAPE makes recommendations for improvements to the Vice Dean for Education and course directors. My role as a member of the SAPE Committee requires 5% effort, which is provided by the SOM. 2006-2009 Co-Chair, Subcommittee on Rewards and Compensation for Teaching Activities, the Abeloff Committee on Educational Value and Rewards – chaired by the late Martin Abeloff, MD, Professor of 30 Medicine and Joseph Cofrancesco, MD, Associate Professor of Medicine, and overseen by Janice Clement, PhD, Vice Dean for Faculty and Edward Miller, MD, Dean of the School of Medicine. This Committee is charged by Dean Miller to document and evaluate faculty education efforts and to determine the most appropriate mechanism to compensate for such effort, adhering to the principles set forth by the School of Medicine. 2011- Director of Medical Student Education in Ophthalmology. The Director oversees the ophthalmology curriculum for the medical students, collaborating with the faculty members at the Wilmer Eye Institute as well as the Office of the Vice Dean for Education. The Director also works with and advises medical students who are interested in entering a career in ophthalmology. OTHER ADMINISTRATIVE APPOINTMENTS American Academy of Ophthalmology 2003-2005 Chair, Uveitis Section, Self-Assessment Committee (in charge of developing a program that will test and assess knowledge deemed necessary for maintenance of certification by the American Board of Ophthalmology) 2007-2012 Member, COMPASS Committee on Uveitis and Ocular Inflammatory Diseases 2008-2010 Member, Annual Meeting Program Committee - Retina/Vitreous American Medical Association 1994-1998 Massachusetts Delegate to the Resident Physicians Section 1995-1996 Resident Representative to the Surgical Caucus Executive Committee 1996-1998 Editorial Board of JAMA, the Journal of the American Medical Association Association for Research in Vision and Ophthalmology 2003-2006 Professional Development and Educational Committee Harvard University, Mather House 1995-1998 Tutor, Health Sciences Advisory Committee International Ocular Inflammation Society 2011Member of the Executive Committee Joseph Richey Hospice (Baltimore, Maryland) 2002Volunteering Attending Physician Joseph Richey Hospice is the only hospice in the United States that is staffed by physicians who donated their time gratis. As attending physician, I helped to admit and examine patients, and work with the staff to ensure that terminally-ill patients are provided with the best 31 comfort and dignity during their last days of life. Maryland Society for Sight 2002Member of the Board of Directors Massachusetts Eye and Ear Infirmary 1994-1998 Continuous Quality Improvement Committee 1997-1998 Fellowship Steering Committee Massachusetts Medical Society 1994-1998 Member, Governing Council of the Resident Physicians Section 1995-1997 Editor-in-Chief, Residents’ Report 1995-1997 Secretary, Governing Council of the Resident Physicians Section 1995-1998 Editorial Board of Vital Signs, the Publication of the MMS 1996-1997 Member, Tax-Supported Medical Care Committee 1997-1998 Member, Board of Trustees 1997-1998 Member, Finance Committee Vietnamese American Medical Association 1998-2001 Vice President of the Executive Committee Co-Chair, Membership Committee 2001-2004 General Secretary of the Board of Directors 2001- Chair, Professor Pham Bieu Tam Award Selection Committee 2004-2007 2005 President Chair of the Planning Committee and Program Director Annual Meeting, September 22-25, Falls Church, Virginia Re-elected as President Vice Chair of the Board of Directors 2007-2010 2010-2013 Vietnamese Medical Association of the Free World 2002-2005 General Secretary of the Executive Committee 2005-2008 President EDITORIAL ACTIVITIES Editorial Board 2008Journal of Ocular Inflammation and Infection Scientific Peer Reviewer 2001American Journal of Ophthalmology 2001Archives of Ophthalmology 2002European Journal of Clinical Microbiology & Infectious Diseases 2002Experimental Eye Research 2001Investigative Ophthalmology and Visual Science 32 200120032003200120042002- Ocular Immunology and Inflammation Ophthalmic Epidemiology Ophthalmic Lasers & Surgery Ophthalmology Pediatric Blood and Cancer Vietnamese Medical Journal ADVISORY COMMITTEES, REVIEW GROUPS, AND STUDY SECTION Food and Drug Administration, Office of Orphan Products Development 2006 Grant Application Study Review Panel 2009 Grant Application Study Review Panel (June and December) Juvenile Diabetes Research Foundation International 2006Medical Science Review Committee PROFESSIONAL SOCIETIES 1987Sigma Xi Honors Scientific Research Society 1990Vietnamese American Medical Association 1990Association for Research in Vision and Ophthalmology 1993Massachusetts Medical Society 1993American Medical Association 1994American Academy of Ophthalmology 1998American Uveitis Society 2002Association for Patient-Oriented Research 2002International Ocular Inflammation Society 2003American Federation for Medical Research 2003American Society of Retina Specialists 2004Macula Society 2005Retina Society CONFERENCE ORGANIZER American Academy of Ophthalmology 2002-2003 Creator of the Subspecialty Day in Uveitis and Ocular Inflammatory Diseases 2003 Program Director, the 2003 Inaugural Subspecialty Day in Uveitis and Ocular Inflammatory Diseases 2005 Program Director, the 2005 Subspecialty Day in Uveitis and Ocular Inflammatory Diseases 2006Instructor, AAO Course on “Current Concepts in the Management of AMD for the Comprehensive Ophthalmologists” 2008 Program Director, the 2008 Subspecialty Day in Uveitis and Ocular Inflammatory Diseases 2010 Program Director, the 2010 Subspecialty Day in Uveitis and Ocular Inflammatory Diseases 2012 Program Director, the 2012 Subspecialty Day in Uveitis and Ocular 33 Inflammatory Diseases Association for Research in Vision and Ophthalmology 2003 Organizer and Moderator, Special Interest Group (SIG) Ocular Imaging of Macular Diseases 2004 Organizer and Moderator, Special Interest Group (SIG) Advances in Ocular Imaging of Macular Diseases 2005 Organizer and Moderator, Special Interest Group (SIG) Blockade of VEGF: Lessons from Early Clinical Experiences 2006 Organizer and Moderator, Special Interest Group (SIG) Novel Treatments and Assessments of Ocular Neovascularization and Macular Edema: Lessons from Early Clinical Experiences 2007 Organizer and Moderator, Special Interest Group (SIG) New Treatments and Assessments of Choroidal Neovascularization and Macular Edema 2008 Organizer and Moderator, Special Interest Group (SIG) New Approaches for Management of Retinal Vascular Diseases 2009 Organizer and Moderator, Special Interest Group (SIG) New Approaches for Diagnosis and Management of Retinal Vascular Diseases and Uveitis 2011 Organizer and Moderator, Special Interest Group (SIG) Synthesizing the Latest data from DME and AMD Clinical Trials: What Are the Implications and New Questions? 2012 Organizer and Moderator, Special Interest Group (SIG) Synthesizing the Latest Data from DME, Neovascular AMD, and RVO Clinical Trials: Significance and Implications Foster Ocular Immunology Society 1998Chair of the Organizing and Scientific Committees FOIS Annual Scientific Meeting 2004- Executive Secretary International Ocular Inflammation Society 2007 Meeting of the International Ocular Inflammation Society Paris, France, September 16-20, 2007 Organizer of Three Symposia on the Role of Inflammation in AMD, Glaucoma, Retinal Degeneration, and Diabetic Retinopathy 2009 Meeting of the International Ocular Inflammation Society Prague, the Czech Republic, May 29 – June 2, 2009 Program Organizer and Moderator 2011 Meeting of the International Ocular Inflammation Society Goa, India, November 12-16, 2011 34 Chair of the Scientific Committee Johns Hopkins University School of Medicine 2008-2013 Course Co-Director Annual Course, Updates on Age-Related Macular Degeneration 2010 Course Co-Director Macula 2010 in conjunction with the 2010 Atlantic Coast Retina Conference 2010 Course Director Current Concepts in the Management of Diabetic Macular Edema and Retinal Vein Occlusion in Conjunction with the 2010 Annual ARVO Convention 2010 Course Director Current Concepts in the Management of Diabetic Macular Edema Uveitic Macular Edema, and Retinal Vein Occlusion in Conjunction with the 2010 American Academy of Ophthalmology Meeting 2011 Course Director Macular Edema: Examining the Evidence http://www.jhasio.com 2013 Course Co-Director Macula 2013 in conjunction with the 2013 Atlantic Coast Retina Conference CONSULTANTSHIPS AND SCIENTIFIC ADVISORY BOARDS 2005Bausch and Lomb, Inc. Member of the Uveitis and Retina Scientific Advisory Board 2006- Santen, Inc. Member of the Retina and Uveitis Scientific Advisory Board 2007- Regeneron, Inc. (arrangements made through the Johns Hopkins Institutional Consultancy Agreement) Member of the Retina Scientific Advisory Board Member of the Steering Committee of the VIEW 1 Study 2008-2009 Sirion Therapeutics, Inc. Member of the Uveitis Scientific Advisory Board 35 2008- Genentech, Inc. (arrangements made through the Johns Hopkins Institutional Consultancy Agreement) Chair of the Diabetic Macular Edema Steering Committee Member of the LUCENTIS® Faculty 2008- Pfizer, Inc. (arrangements made through the Johns Hopkins Institutional Consultancy Agreement) Member of the Retina Scientific Advisory Board 2009- Acucela, Inc. (arrangements made through the Johns Hopkins Institutional Consultancy Agreement) Member of the Retina Scientific Advisory Board 2010- Glaxo Smith Kline, Inc. (arrangements made through the Johns Hopkins Institutional Consultancy Agreement) Member of the Retina and Uveitis Scientific Advisory Boards COMMUNITY AND ALUMNI SERVICES 1985-1989 Volunteer in the Emergency Ward, Yale-New Haven Hospital 1985-1989 Tutor in Chemistry for Students from New Haven public schools 1986-1989 Publisher and Chairman, Yale Scientific Publication, Inc. 1988-1989 Freshman Counselor, appointed by Yale College’s Dean Office 1989-1993 Member, Schools Committee, which Interviews Applicants to Yale College, Yale Club of Philadelphia 1989-1990 Editor-in-Chief, 1990 Penn Med Guide to the First Year 1989Class Agent, Yale Alumni Fund 1990 Event Director and Chairman of the Finance Committee, Penn Med Special Olympics Adult Tournament 1990-1992 Volunteer, Recording for the Blind, Inc., Philadelphia Chapter 1990-1993 Member, Dean’s Evaluations Committee, which evaluates members of the faculty in the School of Medicine for promotion 1990-1993 Member, Penn Medical School Admission Interview Panel 1991-1993 Vice President, Exeter Association of Philadelphia 1992-1993 Editor-in-Chief, 1993 Scope, the Yearbook of Penn Medical School 1992-1993 President and Founding Member, Penn Med Asian American Society 1993President, Penn Medical School, Class of 1993 (elected at graduation) 1994-1997 Member, Lions Club, Boston-Brighton Chapter 1994-2001 Exeter Association of Boston 1994-2001 Member, Schools Committee, which interviews applicants to Yale College, Yale Club of Boston 2001Member, Schools Committee, which interviews applicants to Yale College, Yale Club of Maryland 36 2001200220032004- Consultant for Ophthalmology, Voice of America (VOA), Southeast Asian/Vietnamese Division Lector, Cathedral of Mary Our Queen (Baltimore, Maryland) Volunteer Attending Physician, Joseph Richey Hospice (Baltimore, Maryland) President, Association of Yale Alumni of Maryland RECOGNITION HONORS AND AWARDS 1983-1985 Helen and Paul M. Wilkinson Memorial Academic Scholarship 1984 Tencher Prize for Best Effort in Studying the English Language 1985 Johns Parker Compton Memorial Award for High Scholarship and Leadership 1985 Phillips Exeter Academy Science Department Award for Future Scientist 1985 United States Presidential Academic Award 1985 Secondary School Diploma Summa Cum Laude, Highest Honors 1985-1989 Walter A. Marting Memorial Academic Scholarship 1987 Sigma Xi Scientific Society Summer Research Fellowship 1988 National Science Foundation Summer Research Fellowship 1988 Paul K. Richter Summer Fellowship for Independent Study 1989 Magna Cum Laude, Yale Chapter (Honors Combined Bachelor’s/Master’s Program) 1989-1993 University of Pennsylvania Medical Scholar 1990 National Institutes of Health Medical Summer Research Fellowship 1989-1991 Walter Lewis Croll Academic Scholarship 1991-1992 John R. Lavine Scholarship for High Academic Achievements 1993 Sandoz Award for Outstanding Community Services and Academic Achievements 1995 American Medical Association – Glaxo Achievement Award Recognizing Tomorrow’s Leaders Today 1996 American Medical Association – Glaxo Wellcome Leadership Award 1998 Massachusetts Eye and Ear Infirmary Fellow of the Year Award 1998 Heed Ophthalmic Foundation Fellowship 1998 American Ophthalmological Society – Herman Knapp Fellowship 1999 National Institutes of Health – National Research Service Award 2001 Charles L. Schepens, M.D. Award for Excellence in Retina Research 2001-2006 Career Development Award (K23), National Eye Institute, National Institutes of Health 2002-2004 National Institutes of Health Loan Repayment Award 2003 American Federation for Medical Research Glaxo Smith Kline Scholar 2003 Foundation Fighting Blindness Research Award 2004-2006 National Institutes of Health Loan Repayment Award 2004 Juvenile Diabetes Research Foundation Innovative Award 2005 T. Rowe Price Fellowship for Epidemiologic Study 2006 American Academy of Ophthalmology Achievement Award 37 2007 2007 2008-2011 2008 2009 2009 20102012 2012 2012 American Society of Retina Specialists Honor Award American Academy of Ophthalmology Annual Meeting Best Abstract Award National Institutes of Health/National Eye Institute RO1 Award American Society of Retina Specialist Senior Honor Award Research to Prevent Blindness Foundation Physician Scientist Award Coulter Foundation Innovative Award National Institutes of Health/National Eye Institute R24 Award Association for Research in Vision and Ophthalmology Carl Camras Translational Research Award Club Jules Gonin Travel Grant Research Award American Academy of Ophthalmology Senior Achievement Award INVITED LECTURES 1. The Wilmer Ophthalmological Institute, Johns Hopkins University and Hospitals, Current Concepts in Ophthalmology, Baltimore, Maryland, December 1998. “Scleral Patch Graft in the Management of Scleritis” 2. University of the Philippines, Philippines General Hospital, Manila, July 1999. Visiting Lecturer “Ocular Manifestations of AIDS” 3. The Third International Congress of the Vietnamese Medical Association of the Free World, Paris, France, August 2000. “Ocular Manifestations of Systemic Immunologic Diseases” 4. Annual Convention of the Vietnamese Medical Association of the USA, East Meadowlands, New Jersey, August 2001. “Preserving Vision through Advances in Technology: Where Have We Been … Where Are We Going?” 5. Annual Updates on What’s New in Diabetic Retinopathy and Venous Occlusive Disease, The Wilmer Ophthalmological Institute, Johns Hopkins University, Baltimore, Maryland, October 2001. “Advances in the Treatment of Diabetic Macular Edema: Role of Oxygenation.” 6. The Wilmer Ophthalmological Institute, Johns Hopkins University and Hospitals, Current Concepts in Ophthalmology, Baltimore, Maryland, December 2001. “Supplemental Inspired Oxygen for Hypoxia-Mediated Retinal Diseases: A Pilot Study.” 7. 2002 Annual Diabetes Conference, Johns Hopkins Bayview Medical Center, Baltimore, Maryland, April 2002. 38 “Diabetic Eye Diseases and the Role of Nutritional Control.” 8. The Wilmer Ophthalmological Institute, Johns Hopkins University and Hospitals, Ophthalmology for the Medical Practitioner, Baltimore, Maryland, October 2002. “Diabetes Eye Diseases.” 9. The Wilmer Ophthalmological Institute, Johns Hopkins University and Hospitals, Current Concepts in Ophthalmology, Baltimore, Maryland, December 2002. “Current Concepts in the Diagnosis and Management of Retinal Vasculitis.” 10. Division of Renal Medicine, Johns Hopkins Bayview Medical Center, Baltimore, Maryland, December 2002. “Diabetic Retinopathy: Diagnosis and Management.” 11. Yale Eye Center, Yale University School of Medicine, New Haven, Connecticut, May 15, 2003. Visiting Professor and Ophthalmology Grand Round Speaker “Management of Retinal Vasculitis.” 12. Vietnamese American Medical Association 2003 Annual Convention Orlando, Florida, July 25-27, 2003 “Diabetic Retinopathy: Current Concepts for the Non-Ophthalmologists.” 13. Maryland Society of Eye Physicians and Surgeons 2003 Annual Meeting Columbia, Maryland, October 17, 2003 “New Clinical Trials for Neovascular Age-Related Macular Degeneration.” 14. American Academy of Ophthalmology 2003 Annual Meeting Inaugural Uveitis Subspecialty Day Anaheim, California, November 15, 2003 “Retinal Vasculitis: Current Concepts in Diagnosis and Management.” 15. The Wilmer Ophthalmological Institute, Johns Hopkins University and Hospitals, Current Concepts in Ophthalmology, Baltimore, Maryland, December 2003. “Current Clinical Trials for Neovascular Age-Related Macular Degeneration.” 16. State University of New York at Syracuse The 54th Annual Post-Graduate Course in Ophthalmology December 5-6, 2003 Visiting Professor and Course Faculty Member 17. Updates in Ocular Imaging: Optical Coherence Tomography- The State of the Art The Wilmer Ophthalmological Institute at Johns Hopkins – Invited Speaker January 17, 2004 “Principles of Optical Coherence Tomography Relevant to Clinical Applications.” 39 18. Second Update on Ocular Infectious Diseases The Wilmer Ophthalmological Institute at Johns Hopkins – Invited Speaker May 21-22, 2004 “Diagnostic Molecular Microbiology for Infectious Uveitis.” 19. Second Update on Ocular Infectious Diseases The Wilmer Ophthalmological Institute at Johns Hopkins – Invited Speaker May 21-22, 2004 “Current Perspectives in the Management of Ocular Toxoplasmosis.” 20. Second Update on Ocular Infectious Diseases The Wilmer Ophthalmological Institute at Johns Hopkins – Invited Speaker May 21-22, 2004 “Chronic, Delayed-Onset Endophthalmitis.” 21. University of California at San Francisco Department of Medicine May 26, 2004 Visiting Professor and Renal Grand Round Speaker “Ocular Manifestations of Renal Diseases” 22. Age-Related Macular Degeneration in 2004: From Prevention to Treatment and Bench to Bedside The Wilmer Ophthalmological Institute at Johns Hopkins – Invited Speaker June 4-5, 2004 “The Potential Role of OCT in the Management of Macular Degeneration” 23. Immunology and Inflammatory Diseases 30th Annual Kevin Hill Seminar in Ophthalmology – Visiting Professor Colby College, Waterville, Maine July 19-22, 2004 a. “The Eye as a Target for Inflammation” b. “Posterior Inflammation: Vitritis, Intermediate Uveitis, and Retinal Vasculitis” c. “Infectious Diseases of the Posterior Segments” 24. American Academy of Ophthalmology Annual Meeting New Orleans, Louisiana October 22-26, 2004 Chair: Symposium on New Therapies for Macular Degeneration 25. American Academy of Ophthalmology Annual Meeting New Orleans, Louisiana October 22-26, 2004 Paper Discussant: “Chorioretinal Manifestations of West Nile Virus Infection” 26. American Academy of Ophthalmology Annual Meeting 40 New Orleans, Louisiana October 22-26, 2004 Symposium on An Evidence-Based Medicine Review of the Literature on the Matter of Therapy for Uveitis Invited Speaker: “Evidence-Based Management of Adamantiades-Behçet’s Disease” 27. The Wilmer Ophthalmological Institute, Johns Hopkins University and Hospitals Current Concepts in Ophthalmology, Baltimore, Maryland, December 2-4, 2004. “Fluocinolone Acetonide Intravitreal Implant in the Management of Posterior Uveitis: The One-Year Results of a Randomized Control Trial.” 28. Bascom Palmer Eye Institute, University of Miami School of Medicine Miami, Florida – Visiting Professor February 4-5, 2005 Uveitis for the Other Sub-Specialist a. “Is Retinal Vasculitis a Uveitis?” b. “Scleritis: Patch Graft and Biopsy” 29. Pan-American Congress of Ophthalmology, Pan-American Association of Ophthalmology Santiago, Chile – Invited Speaker March 18-21, 2005 a. “Novel Anti-VEGF Pharmacology for Neovascular AMD” b. “New Therapies for AMD: Where Are We Going in 2005 and Beyond?” c. “New Anti-angiogenic Agents for Choroidal Neovascularization Secondary to Uveitis” d. “How to Approach and Diagnose a Patient with Uveitis?” 30. Midwest Ocular Angiography Conference Whistler, British Columbia, Canada August 3-6, 2005 Presenter: “Cases of Masquerading Uveitis Syndrome” 31. L.V. Prasad Eye Institute, Hyderabad, India October 5, 2005 Visiting Professor “Novel Pharmacologic Therapeutic Approaches for Neovascular Age-Related Macular Degeneration” 32. The 2005 Uveitis Society of India Annual Meeting Jalna, India October 7-9, 2005 Guest of Honor “The Role of Sustained-Release Devices in the Management of Uveitis” 33. The Wilmer Ophthalmological Institute, Johns Hopkins University and Hospitals Current Concepts in Ophthalmology, Baltimore, Maryland, December 1-3, 2005. “Fluocinolone Acetonide Intravitreal Implant in the Management of Posterior 41 Uveitis: The Two-Year Results of a Randomized Control Trial.” 34. World Congress of Ophthalmology Sao Paulo, Brazil, February 19-23, 2006 Invited Faculty Symposia on “Novel Therapy for Ocular Neovascularization” and on “Controversies in the Management on Ocular Inflammatory Diseases” 35. The 2006 International Society of Ocular Pharmacology and Therapeutics Berlin, Germany, March 29-April 1, 2006 Invited Speaker and Moderator “Novel Therapy in the Management of Neovascular Age-Related Degeneration.” “Management of Panuveitis.” 36. New England Eye Center, Tufts University 2006 Innovations in AMD Therapy: A Revolution in Evolution Boston, Massachusetts, April 7-8, 2006 Invited Faculty “Novel Therapeutic Options for Ocular Neovascularization and Diabetic Retinopathy.” 37. Segundo Congreso de la Sociedad Panamericana de Retina y Vitreo Cartagena de Indias, Colombia, May 17-20, 2006 Invited Faculty and Special Guest “Management of Neovascular AMD in 2006 and Beyond: What is the Future?” 38. The 2006 Retinal Physician Symposium Nassau, the Bahamas, May 31-June 1, 2006 Invited Faculty “Ranibizumab for Edema of the Macula in Diabetes: Results of the READ 1 Study” “Current Concepts in the Diagnosis and Management of Ocular Toxoplasmosis” “Immunomodulatory Therapy for Uveitis and Ocular Inflammatory Diseases” 39. The Second French-American Ophthalmological Symposium New York, New York, June 2-3, 2006 Invited Faculty “Where Are We Going in the Management of Ocular Neovascular Diseases?” 40. Albany Medical College Annual Ophthalmology Update Albany, New York, June 15-16, 2006 Visiting Professor “Current Concepts in the Management of Uveitis and Ocular Inflammatory Diseases” 41. The 90th Annual Pacific Coast Oto-Ophthalmological Society Meeting Cabo San Lucas, Mexico, June 23-27, 2006 Special Guest Speaker 42 “Local and Systemic Therapy for Choroidal Neovascularization” “Ocular Manifestations of Systemic Autoimmune Diseases” 42. The 2006 Annual Meeting of the American Association of Diabetes Educators Los Angles, California, August 8-9, 2006 Invited Faculty “Molecular Pathways of Diabetic Retinopathy: Where Are We Going with Therapy in the 21st Century” 43. 2006 Macula in Paris Conference Paris, France, September 5-6, 2006 Invited Faculty “Coming to the Clinics: Potential New Therapy for Neovascular AMD” 44. 2006 Meeting of the Pan-Hellenic Conference on Ocular Inflammation and Infections Island of Crete, Greece, October 27-29, 2006 Guest of Honor and Invited Speaker “Retinal Vasculitis: Pathophysiology and Management” “Management of Uveitis Choroidal Neovascularization” 45. 2006 Annual Meeting of the Philippine Academy of Ophthalmology Manila, the Philippines, November 24-28, 2006 Guest of Honor and Invited Speakers “Current Concepts in the Management of Posterior Uveitis” “Necrotizing Scleritis: Pathogenesis, Diagnosis, and Management” 46. The 2006 Annual Meeting of the Uveitis Society of India Madurai, India, December 2-3, 2006 Invited Speaker “Current Concepts in the Use of Fluocinolone Acetonide Sustained-Release Device in the Management of Posterior Uveitis” “Challenges in Managing Complications of Posterior Uveitis” 47. Macula 2007 Baltimore, Maryland, January 12, 2007 Invited Speaker “Potential Role of VEGF Trap in the Management of Neovascular AMD” 48. University of Louisville Louisville, Kentucky, February 15-16, 2007 Visiting Professor “Retinal Vasculitis: Challenges in Diagnosis and Management” “Coming to the Clinics: Pharmacologic Agents in Clinical Trials for Retinal Diseases” 43 49. Angiogenesis 2007 Bascom Palmer Eye Institute, University of Miami Miami, Florida, February 23-24, 2007 Invited Speaker “VEGF Trap for Diabetic Macular Edema and Neovascular AMD” 50. The 50th Annual Postgraduate Symposium in Ophthalmology William H. Havener Eye Institute The Ohio State University Columbus, Ohio, March 2-3, 2007 Visiting Professor and Invited Speaker “Ocular Manifestations of Systemic Autoimmune Diseases” “Managing Neovascular AMD in 2007 and Beyond” 51. The Phoenix Ophthalmological Society Annual Meeting Phoenix, Arizona, March 22, 2007 Guest of Honor and Invited Speaker “Current Concepts in the Diagnosis and Management of Retinal Vasculitis” 52. New England Eye Center, Tufts University ARMD and Retinal Vascular Diseases 2007: Optimizing Treatments Boston, Massachusetts, March 30-31, 2007 Invited Faculty “Ranibizumab for Macular Edema secondary to Retinal Vein Occlusion” 53. The 2007 Retinal Physician Symposium Fort Meyers, Florida, April 11-14, 2007 Invited Faculty “The Role of VEGF Inhibition in the Management of Diabetic Macular Edema” “White Dot Syndromes: Current Concepts in Diagnosis ad Treatments” 54. The First Annual Uveitis Symposium – Posterior Uveitis: Diagnosis and Treatment University of Illinois Eye and Ear Infirmary, Chicago, Illinois, April 21, 2007 Invited Speaker “Therapy for Uveitic Subretinal Neovascularization” “Diagnostic and Therapeutic Vitrectomy for Uveitis” 55. IX Congreso Internacional Clinica de Oftalmologia de Cali Cali, Colombia, May 24 – 26, 2007 Visiting Professor and Invited Speaker “The Role of HbA1C in the Management of Diabetic Eye Diseases” ”Updates in the Medical and Surgical Therapy for Uveitis” 56. XXVIII Congreso PanAmericana de Oftalmologia Cancun, Mexico, May 30 – June 4, 2007 Invited Speaker 44 “VEGF Trap in the Management of Neovascular AMD” “Retinal Biopsy in the Management of Ocular Inflammatory Diseases” 57. 2007 Annual Convention of the Juvenile Diabetes Research Foundation Global Diabetes Research Forum Saint Louis, Missouri, June 1, 2007 Featured Invited Speaker “Ranibizumab for Edema of the mAcula in Diabetes: A Phase 2 Study – the READ 2 Study. What is Ahead for Patients with Diabetic Macular Edema?” 58. The Third French-American Ophthalmological Symposium Boston, Massachusetts, June 15-16, 2007 Invited Faculty “New Treatments for Neovascular AMD: What Are Coming to the Clinic?” “New Treatments for Uveitis and Ocular Inflammatory Diseases” 59. First Annual Geneva Uveitis Society Conference Geneva, Switzerland, September 12-13, 2007 Invited Faculty “Current Concepts in the Management of Retinal Vasculitis” 60. 2007 Retina Subspecialty Day at the Annual Meeting of the American Academy of Ophthalmology New Orleans, Louisiana, November 9-13, 2007 Invited Speaker “VEGF Trap for AMD” 61. 2008 Les Journees Ophtalmologiques de L’Universite Laval (JOUL) Quebec, Canada, February 7-8, 2008 The Jean Lacerte Lecturer “What Are Coming to the Clinics for the Management of Neovascular AMD?” “Ocular Manifestations of Systemic Autoimmune Diseases” 62. 2008 Macula: Advances in Diagnosis and Therapy (MAT) Torino, Italy, February 9-10, 2008 Invited Speaker and Session Chair “Updates on VEGF Trap for Neovascular AMD” 63. 2008 Angiogenesis, Exudation, and Degeneration Meeting Bascom Palmer Eye Institute, University of Miami Miami, Florida, February 22-23, 2008 Invited Speaker “Updates on VEGF Trap for DME and Neovascular AMD” 45 64. The 7th International Symposium on Ocular Pharmacology and Therapeutics Budapest, Hungary, February 28 – March 2, 2008 Invited Speaker and Session Chair 65. The 33rd Meeting of the Brazilian Retina Society Bahia, Brazil, April 3-5, 2008 Invited Speaker and Program Discussant 66. 2008 Jornadas Nacionales de Oftalmologia Consejo Argentino de Oftalmologia III Symposio Internacional de la Sociedad Argentina de Retina y Vitreo y Uveitis Annual Meeting of the Argentinian Academy of Ophthalmology The 3rd International Symposium of the Argentinian Society of Retina and Vitreous, and Uveitis Buenos Aires, Argentina, May 23-25, 2008 Invited Speaker and Session Chair 67. The 2008 Retinal Physician Symposium Naples, Florida, May 28-31, 2008 Invited Faculty and Program Discussant 68. The 2008 University of Buffalo Annual Ophthalmology Symposium Buffalo, New York, June 6-7, 2008 Visiting Professor 69. XXVII Reunion Annual de Retina The 27th Meeting of the Mexican Retina Society Acapulco, Mexico, June 11-14, 2008 Invited Speaker and Session Chair 70. 2008 Meeting of the Korean Retina Society Yonsei University School of Medicine Seoul, Korea, June 25-26, 2008 Guest of Honor and Visiting Professor 71. 2008 World Congress of Ophthalmology Hong Kong, China, June 29 – July 2, 2008 Invited Speaker and Program Chair for Symposia in Retina and Uveitis 72. 34th Annual Kevin Hill Seminar in Ophthalmology – Retina Update Colby College Waterville, Maine, July 13-17, 2008 Invited Faculty 73. The 26th Visiting Retina Professor The Retina Center at Pali Momi University of Hawaii School of Medicine 46 Honolulu, Hawaii August 30, 2008 74. The 2008 Amsler Club Annual Meeting Newcastle, the United Kingdom October 31 – November 1, 2008 Honored Guest and Invited Speaker 75. The 20th Anniversary Meeting of the Vietnamese Association of Physicians, Dentists, and Pharmacists of Florida Orlando, Florida November 21 – 23, 2008 Honored Guest and Invited Speaker 76. The 10th Annual Research Day Federal University of São Paulo Department of Ophthalmology, Vision Institute São Paulo, Brazil December 11-13, 2008 Visiting Professor 77. The 2009 Macula of Paris Meeting Paris, France January 23-25, 2009 Invited Faculty 78. The 2009 Florida Retina Symposium Sarasota, Florida March 13 – 14, 2009 Invited Faculty 79. The 2009 Retina Physician Symposium Nassau, the Bahamas March 25 – 28, 2009 Invited Faculty 80. 2009 Yale Retina Symposium New York, New York April 3 – 4, 2009 Invited Faculty 81. 2009 Annual Meeting of the Maryland Society of Eye Physicians and Surgeons Baltimore, Maryland May 8, 2009 Invited Faculty 47 82. 2009 International Ocular Inflammation Society Prague, the Czech Republic May 29 – June 2, 2009 Invited Faculty, Program Organizer and Chairman, and Moderator 83. 2009 French American Ophthalmology Symposium New York, New York June 5 – 6, 2009 Program Chairman and Invited Faculty 84. George Washington University School of Medicine Department of Ophthalmology Washington, District of Columbia June 12, 2009 Visiting Professor and Honored Guest Speaker 85. Medical University of Vienna Department of Ophthalmology Vienna, Austria November 13, 2009 Visiting Professor 86. 2009 EuRetina Winter Meeting and Advanced Retinal Therapy (ART) Meeting Vienna, Austria November 14-15, 2009 Invited Faculty 87. The 2010 Macula of Paris Meeting Paris, France January 14 – 16, 2010 Invited Faculty 88. Macula 2010 Baltimore, Maryland January 22-23, 2010 Course Co-Director and Invited Faculty 89. El XLVII Curso de Actualizacion en Oftalmologia: Las Enfermedades Inflamatorias Oculares/Uveitis Mexico City, Mexico February 2-4, 2010 Invited Faculty 90. Angiogenesis 2010 Miami, Florida 48 February 19-20, 2010 Invited Faculty 91. Columbia University, Edward Harkness Eye Institute New York, NY April 1, 2010 Visiting Professor and Grand Round Lecturer 92. Albert Einstein College of Medicine, Montefiore Medical Center Bronx, New York April 2, 2010 Visiting Professor and Grand Round Lecturer 93. 2010 Brazilian Retina Society São Paulo, Brazil April 19-22, 2010 Guest of Honor and Invited Speaker 94. Kansas University, Kansas EyeCon 2010 Kansas City, Missouri May 7, 2010 Visiting Professor and Conference Lecturer 95. 2010 World Congress of Ophthalmology Berlin, Germany June 4-9, 2010 Symposium Organizer, Session Chair, and Invited Faculty 96. 2010 Retina Subspecialty Day at the Annual Meeting of the American Academy of Ophthalmology Chicago, Illinois, October 15-19, 2010 Invited Speaker 97. XIX Reunião de Oftalmologia Lisbon, Portugal November 5-6, 2010 Guest of Honor and Invited Speaker 98. The 2011 Macula of Paris Meeting Paris, France January 14-16, 2011 Invited Faculty 99. The 2011 Atlantic Coast Retina Club and Macula 2011 49 Philadelphia, Pennsylvania January 27-29, 2011 Invited Faculty 100. The Bascom Palmer Eye Institute Angiogenesis 2011 Miami, Florida February 11-12, 2011 Invited Faculty 101. The University of Toronto School of Medicine, Department of Ophthalmology Toronto, Canada March 31 – April 1, 2011 Visiting Professor and Grand Round Lecturer 102. The University of Nebraska School of Medicine, Department of Ophthalmology Omaha, Nebraska April 13 – April 14, 2011 Visiting Professor and Grand Round Lecturer 103. The 5th French American Ophthalmology Symposium Montreal, Canada June 15 – 19, 2011 Co-Chair, Scientific Program Committee and Invited Speaker 104. The 96th Annual Meeting of the Oxford Ophthalmological Congress Oxford, England July 3 – 6, 2011 Invited Faculty and Guest of Honor 105. 2011 Annual Southeast Eye Congress Destin, Florida July 21 – 24, 2011 Invited Faculty 106. Asia Eye Institute 10th Anniversary Scientific Congress Manila, Philippines September 24 – 26, 2011 Invited Faculty and Guest of Honor 107. The 2011 Congress of the International Ocular Inflammation Society Goa, India November 11 – 16, 2011 Chair of the Scientific Program Committee 108. Macula 2012 Congress New York, New York 50 January 19-21, 2012 Invited Faculty 109. IV Jornadas Oftalmologics Caracas, Venezuela January 26 – 29, 2012 Invited Faculty and Guest of Honor 110. Cleveland Ophthalmological Society Cleveland, Ohio February 14, 2012 Featured Faculty and Guest of Honor 111. Case Western University Department of Ophthalmology Cleveland, Ohio February 15, 2012 Visiting Professor and Grand Rounds Lecturer 112. Ohio State University William Havener Eye Institute 55th Annual Symposium Columbus, Ohio March 2-3, 2012 Visiting Professor and William H. Havener Memorial Lecturer 113. The 7th Hippocratic Meeting for Retina, Macula, and Vitreous Thessaloniki, Greece March 16-17, 2012 Invited Faculty and Guest of Honor 114. The 2012 Asia Pacific Academy of Ophthalmology Busan, Korea April 12-16, 2012 Program Chairman, Moderator, and Invited Faculty 115. 2012 Societe Francaise d’Ophtalmologie Annual Congress SFO – Wilmer Eye Institute Joint Symposium Paris, France April 27-30, 2012 Invited Faculty 116. 2013 Glaucoma 2.0: Bench to Bedside Bascom Palmer Eye Institute Miami, Florida January 26, 2013 Invited Faculty 51 117. The Bascom Palmer Eye Institute Angiogenesis 2013 Miami, Florida February 9, 2013 Invited Faculty Updated: 040613